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Abstract 
 
The goal of this study was to identify parameters of balance recovery that may 
be sensitive to postural instability early in the progression of Parkinson’s disease. The 
response to a backwards pull was analyzed in a group of healthy controls and a group 
of adults diagnosed with mild Parkinson’s disease. Video, motion, EMG, and force 
plate data were collected and analyzed. The effect of Parkinson’s disease on strategy 
(single or multiple step response, number of steps, step foot), temporal (reaction time, 
weight shift time, step duration), kinematic (step length, step height, ankle angle), 
kinetic (peak ankle torque, peak landing force) and center of pressure (location at 
liftoff and landing) parameters were examined for the first step in the response. In the 
PD group, subjects were less consistent in their choice of stepping limb over multiple 
trials, but did not take more steps or use a multiple step strategy more frequently than 
the controls. The PD group had a longer weight shift time, but had similar reaction 
times and step duration times compared to HC. The PD group showed different 
motion at the ankle joint prior to liftoff and were in dorsiflexion at liftoff whereas the 
HC were in plantarflexion. HC and PD showed similar ankle motion after liftoff. 
There were no differences in peak torques or peak landing force between the two 
groups; however the center of pressure was further posterior at landing in the PD 
group. These results suggest that further investigation focused on the movement 
preparation stage may be able to identify early markers of postural instability. Further 
study is also necessary to determine the relationship between these parameters and 
clinically defined postural instability. 
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CHAPTER ONE: INTRODUCTION 
 
Background and Motivation 
 Postural instability is a significant problem in Parkinson’s disease (PD) and 
can eventually lead to falls. Unfortunately, the clinical tools available to assess 
postural instability are not sensitive enough to predict those who are at an increased 
risk of falling before a fall occurs. If a laboratory or clinical assessment could be 
developed that is sensitive enough to detect postural instability early in the disease 
progression, then interventions targeting fall risk could be developed to reduce the 
risk of falling. 
 Falls have a devastating effect on quality of life and the current evaluations of 
fall risk are inadequate. The risk of falling in individuals with PD is more than double 
that of the general elderly population and the consequences of a fall can have severe 
impacts on quality of life including fractures, hospitalization, fear of falling, loss of 
independence, and restriction of activities [1-3]. The retropulsion test, one component 
of the Unified Parkinson’s Disease Rating Scale (UPDRS), is used to assess postural 
instability. However, this test has not been shown to be predictive of fall risk. Several 
common characteristics have been identified within PD patients with an increased 
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risk of falling, but they have not been developed into a predictive tool. Currently the 
best predictor of future falls is a history of falls. 
 Balance-related parameters are likely to be important in detecting the early 
signs of postural instability. Studies investigating the step response to a balance 
disturbance have described response changes associated with increased fall risk. 
Significant changes in strategy, temporal, kinematic, and kinetic parameters with age, 
fall history, and PD have been found. However, studies in PD have investigated this 
response only late in the disease progression when postural instability is already 
clinically recognized. The step response to a balance disturbance has not been studied 
early in the progression of PD, which is the time period when the clinician has the 
best opportunity to delay the first fall by introducing an effective intervention.       
Effective interventions exist for those at high risk of falling. In the healthy 
elderly population, multi-factorial programs have been shown to reduce fall risk by 
almost 70% [4]. In PD, compensatory step training has been shown to reduce falls by 
50% [5]. Therefore, there is reason to think that targeted interventions may reduce the 
risk of falling in persons with PD if those at increased risk could be identified prior to 
a fall occurring.  
 
Specific Aims 
The goal of this study was to identify balance recovery parameters that may 
be sensitive to the presence of postural instability early in the progression of 
Parkinson’s disease, prior to clinical detection of postural instability. Video, motion, 
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EMG, and force plate data were collected and analyzed to characterize the response to 
a backwards waist pull of two groups: participants with mild PD while on their PD 
medication and age range matched healthy control participants. The response was 
characterized by response strategy parameters (single vs. multiple step response, 
number of steps, step foot consistency), temporal parameters (reaction time, weight 
shift time, step duration), kinematic parameters (step length, step height, ankle angle), 
kinetic parameters (peak ankle torque, peak vertical force), and center of pressure 
parameters (COP position) during the first step.  
The short term goal of this study was to determine balance-related parameters 
that are sensitive to postural instability early in the progression of Parkinson’s 
disease. This will allow the design of follow-up studies to determine if these 
parameters are sensitive and specific enough to be used as fall risk predictors in 
persons with PD. The long term goal of this research is to better understand the 
reasons for increased fall risk in Parkinson’s disease leading to the development of 
more predictive clinical fall risk assessment tools and the development of more 
effective interventions to reduce fall risk.  
 
Thesis Content 
This document contains four chapters. Chapter 1 consists of an introduction to 
the area of study. Chapter 2 consists of an extensive background survey of relevant 
literature published. Chapter 3 consists of a manuscript reporting the background, 
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methods, and results of the study investigating the effects of Parkinson’s disease in 
the step response to a backwards pull. Chapter 4 consists of a summary of this study. 
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CHAPTER TWO: BACKGROUND 
 
Parkinson’s Disease 
Parkinson’s disease (PD) is a neurodegenerative disorder first described by 
James Parkinson in 1817 and is estimated to affect over 1.5 million people in North 
America [6, 7]. The prevalence of PD increases with age, but there are currently no 
other risk factors or accurate predictors of who is at risk, although it has been shown 
to have a higher prevalence rate in developed countries. PD progressively affects 
mobility and independence, ultimately resulting in an increase in mortality rate of 2-5 
times [8]. There is no treatment that slows or stops the progression of the disease.  
 
Diagnosis. Diagnosis for PD is given through examination by a neurologist or 
movement disorders specialist. The presence of a resting tremor, asymmetry of 
symptoms, and a positive response to Levodopa therapy are an indication of the 
presence of Parkinson’s disease. Physiologically, PD is characterized by the 
progressive death of dopaminergic neurons in the basal ganglia, specifically in the 
substantia nigra. It is estimated that 60-70% of these neurons have already been lost 
at the onset of symptoms [9]. 
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Severity Rating Scales. Parkinson’s disease is a progressive disease, and there are two 
severity rating scales currently in use to quantify its progression: The Unified 
Parkinson’s Disease Rating Scale (UPDRS) and the Hoehn and Yahr scale. The 
Hoehn and Yahr scale was developed in 1967 by Margaret M. Hoehn, MD and 
Melvin D. Yahr, MD.  The Hoehn and Yahr scale consists of 5 stages to assess the 
degree of disability due to Parkinson’s symptoms [10]: 
Stage 1:  Unilateral involvement, minimal or no functional impairment. 
Stage 2:  Bilateral or midline involvement, without impairment of balance. 
Stage 3:  First sign of impaired righting reflexes possibly seen as unsteadiness 
as the patient turns, or loss of balance when pushed from standing with 
eyes closed and feet together. Functionally restricted in activities, 
possibly still able to work, physically capable of being independent, 
disability is mild to moderate. 
Stage 4:  Fully developed, severely disabling disease; patient is still able to walk 
and stand unassisted but is markedly incapacitated. 
Stage 5:  Confinement to bed or wheelchair unless aided. 
The Unified Parkinson’s Disease Rating Scale was developed in 1987 and 
consists of 3 sections: a mentation, behavior and mood section; an activities of daily 
living section; and a motor section.  In each section, the examiner scores the patient 
on a scale of 0-4 on several questions, with 0 being normal and 4 representing the 
worst possible case for that question. The motor section consists of questions for the 
patient as well as several quick physical tests such as finger taps, rising from a chair, 
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a postural stability test (called the retropulsion test or pull test), and rigidity tests 
where the examiner passively moves the limbs to assess rigidity. The scores for each 
question are added to determine the total score, with the maximum being 200. Scores 
are not typically given to the patient, but are used by the clinicians to track the 
progression of the disease.  
 
Pathophyisology 
Anatomy of the Basal Ganglia. The basal ganglia are located beneath the cerebral 
cortex and consist of five nuclei: the globus pallidus, caudate nucleus, putamen, 
subthalamic nucleus, and substantia nigra. The globus pallidus is divided into an 
internal and external region, and the substantia nigra is divided into two regions: the 
dorsal (pars compacta) and ventral (pars reticulata) regions.  The caudate nucleus and 
putamen are often referred to together as the striatum [11, 12].   
 
Function of the Basal Ganglia. The basal ganglia are indirectly involved in 
movement. The basal ganglia are important in preparing the body for voluntary 
movement. They process information needed for planning, triggering, and organizing 
the postural adjustments associated with a voluntary movement. The basal ganglia 
also “allow” movement in a sense, by disinhibiting agonist muscles and inhibiting 
antagonist muscles. The basal ganglia are also involved in sequencing movements 
and motor learning [11, 12].  
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Neurophysiology of the Basal Ganglia. The basal ganglia receive input at the striatum 
from the cerebral cortex, thalamus, and brain stem. Output from the basal ganglia 
leaves from the globus pallidus internal region or the substantia nigra pars compacta 
region. The main output is to the cerebral cortex via the thalamus although it also 
outputs to the brain stem. The basic basal ganglia-thalamo-cortical loop consists of 
input from cerebral cortexÆstriatumÆglobus pallidus and/or substantia 
nigraÆoutput to thalamus. All output from the basal ganglia is inhibitory. This loop 
is somatatopically organized, so that certain parts of the cortex project to certain parts 
of the striatum [11, 12]. There are thought to be two main pathways through the basal 
ganglia. The direct pathway is thought to facilitate movement. The indirect pathway 
is thought to inhibit movement and contains an extra loop involving the subthalamic 
nucleus. The basal ganglia use several different neurotransmitters, but the loop 
between the substantia nigra pars compacta and striatum is the dopaminergic loop that 
is affected in Parkinson’s disease. 
  
Parkinson’s disease and the Basal Ganglia. The basal ganglia contain 80% of the 
total dopamine in the brain [11, 12]. Parkinson’s disease is caused by the death of 
these dopaminergic neurons that project between the striatum and the substantia nigra 
pars compacta. Loss of these projections causes increased activity in subthalamic 
nucleus neurons which leads to increased activity of inhibitory pallido-thalamic 
neurons. This leads to suppression of thalamic activity, ultimately leading to 
suppression of cortical motor areas. By the onset of symptoms in Parkinson’s disease, 
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60-70% of the dopaminergic projections have been lost in the ventrolateral tier of the 
substantia nigra pars compacta [9]. Figure 2-1 illustrates the basal ganglia circuitry 
and what is different in Parkinson’s disease.  
 
 
Figure 2-1.  Abnormalities in neural activity in Parkinson’s Disease. Notice 
that abnormalities in activity in basal ganglia structures lead to increased 
inhibitory activity in the thalamus, leading to decreased excitatory input to the 
cerebral cortex and suppression of the motor cortical areas. Thal: thalamus; 
GPi/GPe: globus pallidus internal/external; SNr/Snc: substantia nigra pars 
reticulata/pars compacta; Sub. Thal: subthalamic nucleus. Plus (+) indicates 
excitatory connection, minus (-) indicates inhibitory connection. In right figure, 
bold black lines indicate increased activity, thin lines indicate reduced activity. 
Figure courtesy of Dr. Paul Cheney.  
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Symptoms of Parkinson’s Disease 
The loss of dopaminergic input from the substantia nigra pars compacta 
causes increased activity in the indirect pathway (which inhibits movement) and 
decreased activity in the direct pathway (which facilitates movement). Both of these 
situations lead to decreased activity of the motor cortex, leading to the common 
symptoms of Parkinson’s disease.  
 
Bradykinesia. Bradykinesia refers to slowed and sometimes incomplete movements.  
Akinesia refers to a lack of movement. Bradykinesia and akinesia are seen in the 
expressionless appearance of the face, shuffling gait, and difficulty initiating 
movements [12]. These are thought to be due to the loss of the dopaminergic neurons 
in the direct pathway, resulting in increased inhibition of the motor cortex [11, 12]. 
 
Tremor and Rigidity. Parkinson’s disease is characterized in part by a resting tremor 
at about 4-6 Hz. Rigidity is manifested as an increased muscle tone resulting in 
resistance to passive movements. These are examples of abnormal motor activation 
due to input from affected projections in the indirect pathway [11, 12].  
 
Postural Instability. Postural instability refers to the impaired balance and 
coordination often seen in those with Parkinson’s disease. Postural stability requires 
proper sensory organization, appropriate motor adjustments to prepare, execute, and 
adjust a movement, and appropriate background muscle tone [13]. Patients with PD 
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often have abnormal postural preparations prior to a voluntary movement, have 
increased sway when standing still, and have abnormal reactions to an external 
perturbation. They are also less able to adapt a postural response to a change in 
support condition [14]. Postural instability combined with other PD symptoms leads 
to an increased risk of falling in those with Parkinson’s disease.   
 
Therapy  
There are currently no treatments that have been shown to slow or stop the 
progression of Parkinson’s disease. However, therapies do exist that improve the 
motor complications associated with the disease. 
 
Levodopa Therapy. The first effective drug therapy for PD is Levodopa, which was 
introduced 30 years ago. Levodopa is effective in lessening the severity of symptoms, 
and is effective initially in over 90% of patients [6, 9]. Levodopa is a dopamine 
therapy, working to replace dopamine that has been lost in the brain. Levodopa 
improves several parkinsonian symptoms such as bradykinesia, rigidity, and tremor. 
It has been shown to improve the control of force and sequencing of muscle 
activations in centrally initiated postural adjustments [15].  
While Levodopa does improve several symptoms, it is not a perfect therapy 
and its long term effects remain unknown [16, 17]. There are concerns with chronic 
use of Levodopa and there are several symptoms that do not respond to Levodopa 
treatment. In particular, motor deficits in PD such as postural instability, freezing of 
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gait, and swallowing problems have been shown to be resistant to Levodopa 
treatment [16, 18]. In a postural sway study by Rocchi et al. it was shown that 
Levodopa treatment actually increased abnormalities in sway, and subjects performed 
better when off medication [15]. In another study on the effects of Levodopa, subjects 
receiving the highest dose had significantly more dyskinesia, hypertonia, infection, 
headache, and nausea as compared to controls on placebo [17]. 
There are several concerns about the effects of chronic use of Levodopa 
including increased dyskinesia, mental changes, and motor fluctuations. Up to 50% of 
patients will experience inconsistent results of taking the Levodopa dose after 2-5 
years, and as the disease progresses it becomes less effective. Some patients 
experience a wearing off effect between doses; others respond normally to the 
medication for a period, followed by periods of minimal response. This inconsistency 
is referred to as a motor fluctuation, and the prevalence increases with increasing 
severity of disease and length of treatment [16]. 
 
Deep Brain Stimulation. Deep Brain Stimulation (DBS) has emerged as an alternative 
to Levodopa treatment for Parkinson’s disease. This treatment involves high 
frequency stimulation through electrodes placed in the subthalamic nucleus or globus 
pallidus of the basal ganglia. This treatment has been shown to improve postural 
control, where Levodopa treatment falls short. This is most likely because DBS can 
affect non-dopaminergic pathways, which are thought to be increasingly affected by 
Parkinson’s disease [19]. However, its relative effectiveness is still controversial due 
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to the interactions of DBS and other therapies and the fact that the mechanism of how 
and why it works is not fully understood.  
 
Postural Instability 
Postural control can be described with three parameters- the center of mass, 
center of pressure, and base of support. The center of pressure is the point where the 
resultant ground reaction force for the body acts. The base of support is the area 
circumscribed by the support surface (the feet when standing). The center of pressure 
changes constantly to account for the change in location of the center of mass. For 
stability, the center of mass should not leave the base of support, so the center of 
pressure is constantly moving around to make sure this does not happen [12].  
The brain receives and processes different types of cues about the position of 
the body and its stability. The vestibular system provides signals related to the 
orientation and movement of the head in space. The organs of the vestibular system 
are located in the inner ear. The somatosensory system provides signals gathered 
from the skin and deep pressure sensors in the body and includes touch, pain, 
pressure, temperature, and proprioception [12, 20]. Visual information is another 
source of postural information. Postural stability requires the proper processing of 
information from all of the sensory systems, appropriate motor adjustments to 
prepare, execute, and adjust a movement, and appropriate background muscle tone 
[13]. 
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Falls in Parkinson’s Disease. Falls have a devastating impact on quality of life and 
Parkinson’s disease greatly increases the risk of falling. The exact mechanism by 
which motor problems associated with PD interact to influence falling is not known, 
but it is clear that the risk of falling is increased. Approximately 30% of the general 
elderly population will fall in a given year. In Parkinson’s disease, this risk has been 
shown to increase to between 46%-68% [1, 21-24]. This is significant because the 
consequences of a fall can have severe impacts on quality of life including fractures, 
hospitalization, loss of independence, and restriction of activities [1-3]. In a recent 
retrospective study of 1,092 Parkinson’s patients by Wielinski et al., 65% of those 
who fell sustained an injury, 22% of those who fell sustained fractures, and 41% of 
those sustaining fractures required surgery. In addition, approximately 27% of the 
entire study group required health care services as a result of falling. This indicates 
substantial costs associated with falling in Parkinson’s disease [22]. Other studies 
have echoed this increased risk of falling and increased risk of injury in Parkinson’s 
disease [21]. In addition to the severe consequences of injurious falls, a fear of falling 
(with or without a previous fall) has been shown to be associated with increased fall 
risk as well as indicating a reduced quality of life in older adults [3, 25].      
 
Fear of Falling. Fear of falling is even more prevalent in Parkinson’s disease than in 
the general elderly population and may or may not stem from actually experiencing a 
fall [3, 25]. This fear can have a significant impact on quality of life as well as on the 
risk of falling. In addition to added general stress, fear of falling impacts quality of 
 16
life by causing the person to restrict physical and social activities they would 
normally participate in [3]. Tinetti et al. developed the Falls Efficacy Scale in order to 
more precisely determine the relationship between fear of falling and actual 
functioning. They found that falls efficacy was strongly associated with tests of 
functioning and that a person’s perception of capability influences behavior, 
regardless of the actual capability. In addition, they found that about 15% of subjects 
who had never fallen reported a decrease in activity due to a fear of falling, indicating 
an unnecessary decline in quality of life [3].  
In addition to the quality of life impacts, fear of falling has also been 
associated with an increase in fall risk [26-28]. This may be due to the decrease in 
activity, a change in postural stability due to increased caution, or a change in balance 
strategy. The exact interaction between fear of falling and postural instability is still 
unknown.  
 
Assessment of Fall Risk. Studies have investigated fall risk factors in both healthy 
elderly and PD populations in an attempt to find a fall risk predictor. While several 
biomechanical and physiological measures have been found to be associated with 
falling, no one factor or combination of factors has been found to predict falling. In 
the healthy elderly population, lower muscle power or strength in the lower 
extremities, worsened postural control and lateral balance, vision impairments, the 
use of multiple medications, cognitive impairment, gait abnormalities, and impaired 
performance on a few clinical balance tests have been found to be associated with 
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falling [29-34]. However, none of these factors have been shown to identify fallers 
prior to a fall occurring. Thus, the best predictor of a future fall is still a history of 
falls.    
Several common characteristics have been identified within PD patients with 
an increased risk of falling: a history of previous falls, increased disease severity and 
duration, depression, dementia, and urinary incontinence [21, 23, 24, 35]. In addition, 
the presence of dyskinesias, freezing episodes, loss of arm swing, fear of falling, 
poorer scores on several measures of the UPDRS test, poor performance on clinical 
measures of motor planning, fine motor control, limb coordination, and gait have also 
shown to be associated with a history of falls [21, 23, 24, 27, 35-37]. However, as in 
the elderly population, these factors have not been able to predict falling in those who 
do not have a history of falls. The difficulty in determining a single clinical test to 
evaluate fall risk most likely has to do with the multi-factorial causes of falls and the 
many different circumstances in which falls occur [38]. In Parkinson’s disease, 
postural instability is a major cause of falls and is specifically tracked as part of the 
UPDRS evaluation. 
 
Assessment of Postural Instability. Postural instability is one of the cardinal 
symptoms of Parkinson’s disease and may lead to falls [39]. The retropulsion test 
(sometimes called the pull test) is widely used to assess postural instability in 
Parkinson’s disease. In this test, which is part of the United Parkinson’s Disease 
Rating Scale (UPDRS) evaluation, the clinician provides a sudden backwards pull to 
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the patients’ shoulders and visually assesses the resulting balance response. Problems 
associated with this test include problems with reliability in executing and scoring the 
test. For example, some examiners warn patients about the pull and perform it several 
times, while others provide no warning and perform it only once. The patient’s 
response is scored on a course scale of 0-4 defined as follows:  0: normal, 1: recovers 
unaided, 2: would fall if not caught, 3: unstable, loses balance spontaneously, 4: 
unable to stand unassisted. The rating scale does not have a specific definition of a 
normal response or a cutoff response that indicates high fall risk. It is implied that 
those at a higher risk of falling require more steps to maintain their balance, while 
those at a lower risk require fewer steps. This test has been shown to be sensitive to 
differences between PD patients with and without a history of falls, however most of 
those studies involve severe cases of PD who already exhibit major balance problems 
and it is not predictive of fall risk [27, 38, 40, 41].  
Recently, more quantitative laboratory tests have shown promising results in 
detecting postural instability earlier in the progression of PD. One study of 55 
subjects with mild to moderate severity PD showed that an increased medial-lateral 
sway, increased sway area, and a more forward position of the center of pressure 
discriminated them from healthy controls [36, 42]. Another recent sway study of 215 
PD patients found that an increased sway area was an independent risk factor for 
recurrent falling in PD [36]. So, there is reason to believe that balance-related 
parameters may provide insight into postural instability early in the disease 
progression. 
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Balance Recovery 
The ability to recover balance after an unexpected perturbation is essential to 
preventing a fall. Studies have shown that with age and certain pathologies, strategies 
for balance recovery change. When presented with a balance perturbation there are 
two types of responses. A fixed-support response is when balance is recovered 
without moving the base of support. Included in this category are the ankle and hip 
response strategies, which involve rotating at the ankle or hip to maintain balance 
without moving the base of support. A change-in-support response is evoked when 
the perturbation is large enough that the fixed-support responses are not as effective. 
This usually involves changing the location and configuration of the base of support. 
A stepping response often requires the use of an anticipatory postural adjustment, 
where the body weight is shifted to the stance limb prior to liftoff of the stepping limb 
[43].  
 Differences in the stepping response have been widely studied in the elderly 
population, who also has an increased risk of falling. Older adults tend to resort to a 
stepping strategy at smaller disturbances than young, they tend to take multiple, 
shorter steps, and tend to step laterally in response to an anterior or posterior 
perturbation [44-47]. In addition, they show larger peak ankle and hip torque and 
power [48, 49], reductions in hip flexion, knee flexion and extension, and ankle 
plantarflexion velocity [50]. Elderly subjects with a history of falls showed smaller 
peak ankle torque, slower reaction time, and slower rate of ankle torque development 
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in response to a forward lean and release perturbation [51], and also tended to step 
laterally in response to a backwards pull [44].  
Studies have also investigated deficits in the sway response in Parkinson’s 
disease. Most of these studies have involved subject populations who are moderately 
to severely affected by the disease and often off medications. In fact, several studies 
have specifically chosen their subject population because of difficulties with balance 
[14, 41, 52, 53]. These studies have been helpful in determining which aspects of 
balance are affected by PD. For instance, PD introduces abnormal foot-floor reaction 
forces, muscle activation patterns, and inflexibility in the feet-in-place response to 
surface translations [13, 54].   
The step response to a balance perturbation has also been investigated in 
Parkinson’s disease. Jacobs et al. have found that moderate and severe PD subjects, 
when off medication, show differences in response compared to healthy controls.  
They use shorter than normal steps, use multiple anticipatory postural adjustments, 
have a longer step foot liftoff time, and are less consistent in the choice of stepping 
limb in the response to a backwards surface translation. This altered response may be 
due to an inability to quickly select an appropriate response since young exhibit 
similar behavior when they are unable to pre-select the stepping foot [53, 55].   
Kinematic and kinetic studies during functional tasks in persons with PD have 
shown significant differences in those parameters during gait, step initiation, and sit-
to-stand tasks. In gait, moderately affected PD subjects on medication showed smaller 
ankle range of motion during the push off and swing phases, and smaller peak 
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plantarflexion at toe off and in the swing phase [56]. In gait initiation, moderate to 
severely affected PD subjects off medication showed decreased force production, 
decreased velocity, and slowed execution of anticipatory postural adjustments [57]. In 
a sit-to-stand task, moderately affected PD subjects on medication showed smaller hip 
flexion torque and slower time to peak torque in the ankle, knee, and hip [58].  The 
differences in kinetics and kinematics during functional tasks may describe certain 
deficiencies that put the PD population at a higher risk of falling. Unfortunately these 
parameters are not well understood for the step response used to recover from a 
balance perturbation. 
 It is important to note that studies in Parkinson’s disease have investigated the 
step response only late in the disease progression when postural instability is already 
clinically recognized. The step response to a balance perturbation has not been 
studied early in the progression of Parkinson’s disease, prior to the presence of 
clinically measured postural instability (H&Y ≤ 2). Since interventions exist for those 
at increased risk of falling, and the consequences of even one fall are severe, it is 
important to determine the appropriate time to begin an intervention targeting fall 
risk. 
 
Interventions to Reduce Fall Risk 
Effective interventions exist for those at high risk of falling. In the healthy 
elderly population, multi-factorial programs together with targeted individual 
therapies are the most effective in fall prevention [4]. These programs typically 
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include exercise and physical therapy, gait and balance training, advice on proper use 
of assistive devices, review and modification of medications, treatment of postural 
hypotension, modification of environmental hazards, and targeted medical 
assessments. Individual interventions are then determined based on the factors most 
prevalent in the patient. These multi-factorial interventions have reduced fall risk by 
up to 66% [4].  
A similar multi-factorial approach is probably necessary to reduce fall risk in 
persons with PD. Studies have investigated the effects of physical therapy and 
balance and gait training on PD fallers, and while they have not been able to 
conclusively prevent falls, they have seen improvements in balance and gait measures 
[59-61]. Stankovic et al. studied the effect of physical therapy on balance in healthy 
elderly, PD fallers, and PD non-fallers [60]. Physical therapy including regular 
physical activity, walking with a visual stimulus, stepping, playing recreational 
sports, strategies for correction of motor function such as attention, maintaining an 
upright posture, and elongation of muscles was applied for 30 days. Balance measures 
included quiet standing tasks, internal perturbation tasks, and an external 
perturbation. This study showed that the physical therapy program improved all of the 
balance measures, especially the tandem stance, single leg stance, functional reach, 
step, and external perturbation tests. While this study was not able to show the effect 
on falls, it did find an improvement in some of the measures that are used to assess 
fall risk.  
 23
Other studies on gait and compensatory step training in PD have shown 
improvements in both gait and step parameters and one study showed a 50% decrease 
in falls in the group that received the intervention [5, 59]. Therefore, there is reason to 
think that targeted interventions may reduce the risk of falling in persons with PD.  
 
Summary 
 Parkinson’s disease is a debilitating disease and postural instability leading to 
falls is one of the most disabling symptoms. Experiencing a fall severely impacts 
quality of life on physical, economic, and psychological levels. While there are 
effective interventions that reduce fall risk, they are often not implemented until after 
the first fall due to the lack of a predictive measure. If laboratory or clinical 
assessments were available to identify the appropriate time to begin targeted 
interventions, fall risk could be significantly reduced. Prevention of that first fall 
would allow persons with Parkinson’s disease to maintain an independent and active 
lifestyle as long as possible.   
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CHAPTER THREE: STUDY 
 
Abstract 
Background. Postural instability leading to falls is one of the most disabling 
symptoms of Parkinson’s disease (PD) and the current methods available to assess 
postural instability are not sensitive enough to predict those at higher risk of falls. 
This study sought to investigate parameters of balance recovery that may be sensitive 
to postural instability early in the progression of Parkinson’s disease.  
 
Methods. The response to a backwards pull was measured in a group of adults 
diagnosed with Parkinson’s disease (PD: age range 48-77, mean age 63.2 ± 8.9 years, 
H&Y 2) and a group of age-range matched, healthy controls (HC: age range 48-79, 
mean age 68 ± 11 years). Video, motion, EMG, and force plate data were collected 
and analyzed. The effect of Parkinson’s disease on strategy (number of steps, step 
foot), temporal (reaction time, weight shift time, step duration), and kinematic/kinetic 
(step length, step height, ankle angle, peak ankle torque), and center of pressure 
(location at liftoff and landing) parameters were examined for the first step in the 
response to a backward waist pull. 
 
Results. The PD group was less consistent in their choice of stepping limb across 
multiple trials, but did not take a larger number of steps or use a multiple step strategy 
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more frequently than the controls. The PD group had a longer weight shift time, but 
had similar reaction times and step duration times. The PD group utilized a different 
motion at the ankle joint prior to liftoff. At liftoff, the PD subjects were in 
dorsiflexion, whereas the HC subjects were in plantarflexion. No group differences 
were observed in ankle joint motion after liftoff, in the peak ankle torques, or in the 
peak landing forces. However, the center of pressure was located further posterior at 
landing of the first step in the PD group, compared to the HC group. 
 
Conclusions. These results demonstrate that biomechanical indicators of postural 
instability may be present in the initial movement preparation stage in the response, 
which is the time period between disturbance onset and liftoff time of the first step.   
Future studies should further investigate this stage in the response and should 
investigate the relationship between these parameters and postural instability.  
 
Introduction 
 Postural instability is a significant problem in Parkinson’s disease (PD) and 
eventually leads to falls. Unfortunately, the clinical tools available to assess postural 
instability are not sensitive enough to predict those who are at an increased risk of 
falling before a fall occurs. If laboratory or clinical assessments could be developed 
that are sensitive enough to detect postural instability early in the disease progression, 
then interventions targeting fall risk could be developed to reduce the risk of falling. 
This study aims to identify parameters related to balance recovery that may be 
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sensitive to postural instability prior to the presence of clinically recognized postural 
instability in Parkinson’s disease.  
 
Clinical Need. Falls have a devastating effect on quality of life and the current 
evaluations of fall risk are inadequate. The risk of falling in individuals with PD is 
more than double that of the general elderly population, with up to 68% of patients 
falling per year [1-4]. The consequences of a fall can have severe impacts on quality 
of life including fractures, hospitalization, loss of independence, and restriction of 
activities [2, 5, 6]. Given the physical, psychological, and economic impacts of 
falling, it is important to be able to assess risk and prescribe appropriate therapies and 
interventions. While great strides have been made in treatment of most PD symptoms, 
postural instability is often unresponsive to medications and no tool currently exists to 
accurately predict fall risk.  
The current methods available to assess postural instability are not sensitive 
enough to predict those at a higher risk of falling before a fall occurs. The 
retropulsion test is widely used to assess postural instability in Parkinson’s disease. 
However, problems associated with this test include reliability in executing and 
scoring the test. For example, some examiners warn patients about the pull and 
perform it several times, while others provide no warning and perform it only once.  
In addition, the patient’s response is scored on a course scale of 0-4 defined as 
follows:  0: normal, 1: recovers unaided, 2: would fall if not caught, 3: unstable, loses 
balance spontaneously, 4: unable to stand unassisted. This test has been shown to be 
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sensitive to differences between PD patients with and without a history of falls, 
however many of those studies involve only cases of PD who already exhibit balance 
impairments and the retropulsion test is not predictive of fall risk [7-10]. More recent 
studies with larger sample sizes and a wider range of severity levels have shown 
promising results in detecting postural instability in early PD using laboratory 
measures of postural sway [11, 12].  
 
Interventions to Reduce Fall Risk. Effective interventions exist for those at high risk 
of falling. In the healthy elderly population, multi-factorial programs together with 
targeted individual therapies are the most effective in fall prevention and have 
reduced fall risk by up to 66% [13]. Multi-factorial programs combine several 
therapies such as physical therapy, strength and balance training, and home 
modifications to affect the multi-factorial causes of falls. A similar approach is 
probably necessary to reduce fall risk in persons with PD. Studies on gait and 
compensatory step training in PD have shown improvements in both gait and step 
parameters and one study showed a 50% decrease in falls after the intervention [14, 
15]. Therefore, there is reason to think that targeted interventions will reduce the risk 
of falling in persons with PD if those at increased risk could be identified prior to a 
fall occurring. 
 
Assessment of Fall Risk. There is currently no tool to accurately predict fall risk. 
However, several common characteristics have been identified within PD patients 
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with an increased risk of falling: a history of previous falls, increased disease severity 
and duration, depression, dementia, and urinary incontinence [1, 16-18]. In addition, 
the presence of dyskinesias, freezing episodes, loss of arm swing, fear of falling, 
poorer scores on several measures of the Unified Parkinson’s Disease Rating Scale 
(UPDRS), poor performance on clinical measures of motor planning, fine motor 
control, limb coordination, and gait have also been shown to be associated with a 
history of falls [1, 9, 11, 16-19]. However, none of these factors have been shown to 
identify fallers prior to a fall occurring. Thus, the best predictor of a future fall is still 
a history of falls.    
 
Balance Recovery. Balance-related parameters are likely to be important in detecting 
the early signs of postural instability. The ability to recover balance after an 
unexpected perturbation is essential to preventing a fall. Significant changes in 
strategy, temporal, kinematic, and kinetic parameters with age, fall history, and 
Parkinson’s disease have been found. 
 Studies into the feet-in-place response to surface translations have shown that 
PD causes abnormal foot-floor reaction forces, muscle activation patterns, and 
inflexibility [20, 21]. Kinematic and kinetic studies during functional tasks have 
shown differences in those parameters during gait, step initiation, and sit-to-stand 
tasks [22-25].  
The step response to a balance perturbation has also been investigated in 
Parkinson’s disease. Jacobs et al. have found that PD subjects, compared to healthy 
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controls, use shorter than normal steps, use multiple anticipatory postural 
adjustments, have a longer step foot liftoff time, and are less consistent in the choice 
of stepping limb in the response to a backwards surface translation [26, 27]. This 
altered response may be due to an inability to quickly select an appropriate response 
since young exhibit similar behavior when they are unable to pre-select the stepping 
foot [28].   
 Studies into postural stability in Parkinson’s disease have primarily focused 
later in the disease progression when postural instability is already clinically 
recognized or chosen their subject population specifically for balance deficits [10, 27, 
29, 30]. The step response to a balance perturbation has not been studied early in the 
progression of Parkinson’s disease, prior to the presence of clinically measured 
postural instability (Hoehn &Yahr ≤ 2). Since interventions exist for those at 
increased risk of falling, and the consequences of even one fall are severe, it is 
important to determine the appropriate time to begin an intervention targeting fall 
risk.   
 Differences in the stepping response have been more widely studied in the 
elderly population, which also has an increased risk of falling. Older adults tend to 
resort to a stepping strategy at smaller disturbances than young, they tend to take 
multiple, shorter steps, and tend to step laterally in response to an anterior or posterior 
perturbation [31-34]. In addition, they show larger peak ankle and hip torque and 
power [35, 36], reductions in hip flexion, knee flexion and extension, and ankle 
plantarflexion velocity [37]. Elderly subjects with a history of falls show smaller peak 
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ankle torque, slower reaction time, and slower rate of ankle torque development in 
response to a forward lean and release perturbation [38], and also tend to step 
laterally in response to a backwards pull [31].  
Therefore, in our search for balance recovery parameters that may be sensitive 
to the onset of postural instability in individuals with PD, it seemed appropriate to 
investigate parameters related to strategy, temporal, kinematic, and kinetic aspects of 
the response. Once the most sensitive parameters have been identified, a follow-up 
study can be designed to establish the sensitivity and specificity of these parameters 
in detecting signs of early postural instability caused by PD. 
 
Study Aims and Hypotheses. This study aimed to identify balance recovery 
parameters that may be sensitive to the presence of postural instability in people with 
Parkinson’s disease early in the progression of the disease, prior to clinically 
measured postural instability. The response to a backwards waist pull was 
characterized in a group of PD participants at Hoehn & Yahr severity level 2, who by 
definition do not exhibit signs of postural instability, and a group of age-range 
matched healthy controls. Video, motion, EMG, force plate, and load cell data was 
collected and analyzed to characterize the response in terms of response strategy 
(single vs. multiple step response, number of steps, step foot consistency), temporal 
parameters (reaction time, weight shift time, step duration), kinematic parameters 
(step length, step height, ankle angle at liftoff and landing, peak ankle angle), kinetic 
parameters (peak ankle torque, peak vertical force), and center of pressure parameters 
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(COP position at liftoff and landing) during the first step. This was an exploratory 
study designed to determine which parameters of balance recovery justify further 
investigation in the search for early markers of postural instability. 
 
Methods 
Subjects. Ten subjects with idiopathic Parkinson’s disease and 10 healthy controls 
(PD: age range 48-77, mean age 63.2 ± 8.9 years, H&Y 2; HC: age range 48-79, 
mean age 67.2 ± 10.9 years) were tested. All participants had a normal score on the 
Mini-Mental State Exam (MMSE) [39] and Beck Depression Index [40] and had 
mobility independent of any assistive devices. All participants gave informed consent 
for the study as approved by the Institutional Review Board at the University of 
Kansas Medical Center (KUMC). Study participants included persons qualifying for 
the study regardless of gender, race, or ethnic background. 
Healthy controls were recruited using the Grayhawk database and from the 
community. Prospective healthy control participants were phone interviewed and 
asked to respond to a questionnaire concerning their health history. All healthy 
control participants were screened by a physical therapist, who was supervised by a 
geriatric physician specialist, using a medical history and a physical examination 
based on standardized cardiovascular, musculoskeletal and neurological evaluations. 
All healthy controls were living independently in the community and had no 
significant history of musculoskeletal, neurological, or cognitive impairments.  
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 All PD participants were recruited from the KUMC Parkinson’s Disease and 
Movement Disorder Center patient pool. Only those diagnosed with PD by the 
director of the Parkinson’s Disease and Movement Disorder Center were considered 
for this study. Persons with atypical PD were not included. All PD participants were 
on dopaminergic medications and were tested in their best medication “ON” state. 
Patients who had undergone Deep Brain Stimulation (DBS) were excluded since it is 
unclear whether DBS positively or negatively affects balance. PD participants were 
given the UPDRS evaluation by a movement disorders specialist to ensure up-to-date 
scores. All PD participants had no other significant history of musculoskeletal, 
neurological, or cognitive impairments other than those associated with Parkinson’s 
disease. All PD participants were Hoehn & Yahr 2 with UPDRS motor scores ranging 
from 9-38 (mean = 20).  
 
Task. The participant stood in a comfortable upright position with arms crossed at the 
chest. The participant wore a safety harness connected to an overhead frame designed 
to prevent the participant from contacting the floor in the event of a fall and a 
research assistant stood behind the participant to ensure safety. The participant wore 
an adjustable but rigid waist harness attached in the back through a cable to the 
weight-drop mechanism which has been previously described [34]. When the 
mechanism was released, it delivered a posterior waist pull. The weight dropped was 
20% body weight and the pull distance was equal to 8.7% of waist height, 
corresponding to a 5º equivalent disturbance angle [34]. The magnitude of the pull 
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was chosen to be large enough that the subject would have to utilize a step response 
to regain his/her balance. The participant was instructed to respond naturally to the 
posterior waist pulls. Trials were repeated until three good trials were obtained for all 
subjects. 
 
Experimental Measurements. Video, Motion, force plate, EMG and load cell data 
were collected for each trial. Motion data were sampled at 120 Hz using reflective 
markers and a six camera Vicon 512 (Vicon Peak, Lake Forest, CA) motion analysis 
system. Markers were placed bilaterally on the 2nd metatarsal, lateral malleolus, heel, 
calf, and lateral femoral condyle. Muscle electromyographic data was measured using 
an eight channel Noraxon telemetered surface electrode system (Noraxon, Scottsdale, 
AZ). Electrodes were placed bilaterally on the tibialis anterior. Foot/floor reaction 
forces and moments were measured using three AMTI (Advanced Medical 
Technology Inc.; Watertown, MA) six-component force plates. A biaxial custom built 
load cell measured the forces in the cable attached to the waist harness.  
 
Data Analysis. Motion data were filtered with a Woltring filtering routine (MSE=20) 
in the Vicon software, prior to being exported for post-processing. EMG data were 
full wave rectified. All analog data were sampled at 1080 Hz using a 16-bit A/D data 
acquisition system controlled with the Vicon workstation and filtered using a second 
order low pass Butterworth filter with a cutoff frequency of 50 Hz. Initial and final-
time artifacts were minimized using forward and backward reflection of the data [41], 
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and phase shift was eliminated by using forward and backward passes [42]. Data from 
all trials were processed using MATLAB (Mathworks, Natick, MA, USA).   
 
Strategy parameters. Strategy parameters were determined by analyzing video taken 
during the trials. These parameters consisted of: the number of steps taken to regain 
balance, whether the subject used a single or multiple step response, and whether the 
subject was consistent in the foot used for each step (e.g. right or left). A subject was 
classified as using a multiple step response if they used more than one step to regain 
balance in any of the three trials. A subject was classified as being consistent in the 
choice of step foot if they used the same foot for the first step in all of the three trials. 
A step was defined as a change in the base of support which requires a foot liftoff and 
a translation of the foot.  
 
Temporal parameters. Temporal parameters were determined by analyzing the load 
cell, force plate, EMG, and motion data. The load cell signal was used to quantify the 
disturbance onset, peak force, and impulse strength (area under the force-time curve). 
All temporal parameters are reported relative to the onset of the disturbance. A 
threshold method was used to determine the time when the muscle was activated. The 
EMG threshold value was defined as the mean plus five standard deviations of the 
signal over a 50 ms window prior to the disturbance. EMG onset time was defined as 
the first time when 25 consecutive data points exceeded the threshold. Reaction time 
was defined as the time between the disturbance onset and the first tibialis anterior 
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muscle onset time. Liftoff time was defined as the time between the disturbance onset 
time and the unloading of the vertical force component under the foot used for 
stepping (vertical force < 3% body weight). Landing time was defined as the time 
between the disturbance onset and the time when the vertical force component under 
the landing foot increased to above the threshold (vertical force > 3% body weight). 
Weight shift time was defined as the time between reaction time and liftoff time.  
Step duration time was defined as the time between liftoff and landing time.   
 
Kinematic and Kinetic Parameters:  Step length was determined by the resultant 
distance traveled by the heel marker between the liftoff and landing times. Step height 
was defined as the maximum vertical displacement of the heel marker between liftoff 
and landing times. Step length and height are scaled to the subject’s height.  
Marker trajectories, foot-floor reaction forces, and anthropometric 
measurements were used with Vaughn’s three dimensional inverse dynamics model 
[43] to determine the ankle angle and torque parameters. This model uses a 3-segment 
approximation of the lower limb (foot, shank, and thigh) and is based on the Newton-
Euler equations. Ankle plantarflexion (PF)/dorsiflexion (DF) angle was extracted for 
three distinct times (disturbance onset, liftoff, and landing) and for two stages of the 
first step in the response: stage one was defined as disturbance onset to liftoff and 
stage two was defined as liftoff to landing. Ankle angle at liftoff and landing was 
calculated relative to the initial configuration (mean of the ankle angle during a one 
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second window just prior to disturbance onset). Within each stage, the maximum PF 
angle and DF angle were calculated relative to the angle at the beginning of the stage.   
Within each stage the peak PF and peak DF torques were calculated relative to 
the values at the beginning of the stage. The peak vertical landing force was 
calculated as the maximum vertical force after landing and was scaled to body 
weight. 
 
COP Parameters. The whole-body center of pressure (COP) was analyzed from 
disturbance onset time to landing time of the first step. The anterior-posterior (AP) 
and medial-lateral (ML) displacements of the COP relative to the location at 
disturbance onset were determined at liftoff and landing of the first step.   
 
Statistical Analysis. Statistical analysis was done with SPSS 15.0 (SPSS Inc., 
Chicago, IL, USA). All three trials for each subject were used to evaluate group 
differences in strategy. A subject was defined as using a multiple step response if they 
used more than one step for any of the three trials. A subject was defined as being 
consistent in their choice of stepping limb if they used the same foot for all three 
trials. A p-value ≤  0.05 was used to establish significant differences. A Fisher’s two-
tailed exact test was used to determine group differences in multiple vs. single step 
responses and consistency in choice of stepping limb. The Wilcoxon Rank Sum test 
was used to evaluate group differences in the number of steps utilized in the response.   
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Since the single step strategy may be fundamentally different from the 
multiple step strategy, only trials in which a multiple step strategy was utilized were 
included in the remaining analysis (temporal, kinematics, kinetics, COP). Preliminary 
results did show that a few parameters were statistically different between the 
multiple and single step strategy, confirming our assumption. Elimination of single 
step trials left 8 participants in each group, most of whom had at least 2 trials where 
they utilized a multiple step strategy. An additional HC and PD subject were not 
included in the ankle angle and torque calculations because of data collection 
problems with the Vicon markers.  
Results from trials utilizing a multiple step response within a subject were 
averaged across the repeated trials and analyzed by separate MANOVAs for temporal 
(reaction time, weight shift time, step duration), kinematic (step length, step height, 
ankle angle at liftoff and landing, stage one and two max PF and max DF), kinetic 
(stage one and two peak PF and DF torque, peak vertical force at landing), and center 
of pressure (AP and ML position at liftoff and landing) sets of variables to determine 
the overall effect of group. Follow up t-tests were then done to investigate the 
individual parameters within each set that were the most sensitive to the presence of 
PD. Corrections for type 1 error were not done due to the fact that this is an 
exploratory study looking for parameters that may be sensitive to postural instability 
in early PD. Future studies, with the appropriate power and focused on the most 
promising parameters as indicated by the results of this study, will be needed to 
confirm these findings. 
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An initial MANOVA on all subjects’ anthropometric (weight and height), 
initial stance (stance width, COP position under each foot) and pull characteristics 
(peak, duration, impulse) revealed no group differences (p = .944) and will not be 
considered further. 
 
Results 
 The backwards pull consistently resulted in stepping responses in the HC and 
PD participants. All subjects regained his/her balance by taking between one and four 
steps. 
 
Strategy. To evaluate differences in the step strategy variables, all trials from all 
subjects were evaluated. The average number of steps and the percentage of trials 
resulting in a multiple stepping strategy were remarkably similar between HC and PD 
(number of steps: 1.75 (.57) vs. 1.77 (.59); p=.940, percentage of multiple stepping 
trials: 90% vs. 80%; p >.999). However, only 50% of the PD participants were 
consistent in their choice of limb used for the first step, compared to 80% of the HC 
participants. Fisher’s two-tailed exact test did not reveal a significant difference (p = 
.350). Only trials resulting in a multiple step strategy were used in the rest of the 
analysis. 
 
Temporal. A MANOVA on the dependent temporal variables did not reveal a 
significant main effect of group (p = .092). In the follow up tests, the only temporal 
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variable that showed a significant group difference was weight shift time (HC: 222 
ms; PD: 500 ms; p = .023). Reaction time was similar between groups, and step 
duration time was longer in PD but not to a significant level.   
 
Kinematics. A MANOVA on the dependent kinematic variables did not reveal a 
significant main effect of group (p = .280). In the follow up tests, the first stage ankle 
angle parameters showed significant group differences (liftoff angle (p = .016), max 
PF (p = .019), and max DF (p = .004)). During the first stage, the two groups showed 
a different trend in ankle motion. For example, the HC tended to go into 
plantarflexion (PF) immediately after disturbance onset and then rotated into 
dorsiflexion (DF) prior to liftoff, whereas the PD tended to go directly into DF. 
Therefore, at liftoff, the PD were in DF, whereas the HC were in PF (HC: 1.51 (3.84); 
PD: -4.10 (3.64); p = .016). At landing, PD were in more DF than HC (HC: -1.27 
(3.91); PD: -5.09 (5.24); p = .148), but not to a significant level. The PD group had 
larger peak DF angles (HC: -.866 (1.32); PD: -4.89 (2.66); p = .004) and smaller peak 
PF angles (HC: 4.10 (1.66); PD: 1.68 (1.67); p = .019) during the onset of disturbance 
to liftoff stage. Motion during the liftoff to landing stage was similar between groups. 
The length and height of the first step were also similar between groups. 
 
Kinetics. A MANOVA on the kinetic dependent variables did not reveal a significant 
main effect of group (p = 0.571). In the follow up tests, none of the individual 
variables showed significant group differences. 
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COP. A MANOVA on the COP dependent variables did not reveal a significant main 
effect of group (P = 0.228). In the follow up tests, the COP AP position at landing 
showed a difference between groups. The COP moved further posterior between 
disturbance onset to landing time in PD compared to HC (HC: 42 mm; PD: 71 mm; p 
= .032). 
  
Discussion 
 This was an exploratory study designed to determine which parameters of 
balance recovery justify further investigation in the search for early markers of 
postural instability. MANOVAs were performed on four different sets of variables to 
conservatively investigate group differences, and then used follow up t-tests to 
investigate the sensitivity of individual parameters, even if the MANOVA result did 
not indicate a significant group difference. A focused follow-up study with 
appropriate statistical power must be designed to confirm these findings. The goal of 
this study was to identify the parameters that warrant further investigation. Thus, we 
will focus on the most sensitive findings, keeping the limitations of the approach in 
mind.   
 We found that even early in the progression of PD, prior to any clinical 
diagnosis of postural instability, a few differences in the response to a backwards pull 
are present. This change in response seems to be most reflected in the initial 
movement preparation phase for the first step taken in the multiple step strategy.   
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Strategy. Parkinson’s disease did not affect the utilization of a single step response 
compared to a multiple step response. This may be a result of the magnitude of the 
disturbance used in this study. Even so, the PD subjects, compared to the HC, were 
less consistent in using the same foot for the initial step in the multiple step strategy. 
This result is consistent with the study by Jacobs et al. who showed that healthy 
subjects tend to step consistently with the same foot [28].  
 
Temporal. PD did not affect the reaction time or the duration of the first step.  
Previous studies have shown that PD does not affect the reaction time after an 
external perturbation [20, 30, 44]. In the present study, PD did increase the weight 
shift time, which is the time between muscle activity onset and step foot liftoff. The 
inconsistent choice of the foot used for the initial step together with the longer weight 
shift time in the PD, compared to the HC, may be demonstrating what Jacobs et al. 
reported when healthy subjects were unable to pre-select their stepping foot: they had 
several anticipatory postural adjustments, leading to longer liftoff times compared to 
the condition where they were allowed to choose their stepping foot [28]. 
 
Kinematics. PD did affect the kinematics of the first step used in the response, but 
only prior to liftoff of that step. Both the ankle motion prior to liftoff and the ankle 
configuration at liftoff demonstrated group differences. The fact that the HC group 
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was in plantarflexion at liftoff is consistent with the results reported by Luchies et al. 
[34].     
 
Kinetics. PD did not affect the torque generated at the ankle in response to the 
backwards pull. This is consistent with a study by Maki et al. [45] who investigated 
sit-to-stand in PD. They also showed similar magnitudes of ankle torque compared to 
healthy controls, but did see differences in the time to peak torque, which was not 
investigated here. 
 
COP.  The center of pressure differences observed indicate that the PD moved further 
posterior than the HC prior to landing. It is also clear that the AP movement of the 
COP is where the group differences are most likely going to be found, as the ML 
movements were very similar in the two groups.   
 
Conclusions.  Several differences in the response to a backwards pull were found in a 
PD population that has yet to clinically demonstrate balance impairments or postural 
instability. Most of the differences between the two groups were found in the 
movement preparation phase of the response (i.e. prior to liftoff of the first step). The 
weight shift, ankle kinematics, and center of pressure are important areas to 
investigate further. These results suggest that further investigation focused on the 
movement preparation stage may be able to identify early markers of postural 
instability. Further study is also necessary to determine the relationship between these 
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parameters and clinically defined postural instability. It will also be necessary to 
develop clinic-based tests that can be used to monitor those parameters that are 
sensitive enough to detect the postural instability in the early stages of PD.  
 
Limitations. This study has limitations. For one, there was a small sample size and 
large number of parameters tested. As mentioned above, further studies with a more 
focused approach and appropriate statistical power are necessary to validate these 
findings. Another limitation of the study is that the same number of trials was not 
used for every subject (i.e. only trials that involved multiple steps were included).  
Further studies should be consistent in the number of trials used in the analysis. 
Finally, the subject population demonstrated a wide range of ages (48-77), UPDRS 
scores (10-60), and disease duration (1-13 years), and the effects of these conditions 
on the response parameters were not investigated. Further studies should investigate 
whether or not these conditions affect balance parameters.  
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Figure 1. Illustration of temporal parameters. (A) Vertical forces from the left, 
right, and back force plate illustrating liftoff, landing, second liftoff, and step 
duration. (B) Top trace is load cell normal force, middle trace is TA EMG, 
bottom trace is step foot vertical force illustrating reaction time and weight 
BA
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Figure 2. Demonstration of ankle angle parameters. Graph is a 
representative healthy subject from disturbance onset to liftoff. 
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Figure 3. Strategy characteristics of step response. Left Axis: Multiple step response- 
more than one step was use in at least one trial; Consistent step limb choice- stepped 
with the same limb for all trials. Right Axis: Number of Steps- average number of 
steps in response. 
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Temporal Parameters, HC vs. PD
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Figure 4. Temporal Parameters: RT (Reaction Time), WST (Weight Shift Time), 
STD (Step Duration Time).  
* p<.05 in follow-up t-test 
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Figure 5. Group Average Ankle PF/DF Angle. Light trace is healthy, dark trace 
is PD. Top graph: disturbance onset to liftoff. Bottom graph: liftoff to landing. 
Solid lines are group averages, dotted lines are +/- 1 group standard deviation. 
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Ankle Angle, HC vs. PD
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Figure 6. Ankle Angle Parameters. Positive is plantarflexion (PF), negative is 
dorsiflexion (DF). Liftoff and landing angles are relative to initial conditions. Max PF 
and DF in each stage are relative to angle at beginning of the stage. The number 1 
indicates stage one (disturbance onset to liftoff) and 2 indicates stage two (liftoff to 
landing).  
* p<.05 in follow-up t-test 
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Figure 7. Kinetic parameters: Peak dorsiflexion (DF) and plantarflexion (PF) 
in stage one (disturbance onset to liftoff) and two (liftoff to landing), peak 
landing force. Torques are normalized to subject height times mass, landing 
force is normalized to subject mass. 
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COP Parameters HC vs. PD
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Figure 8. COP parameters: AP and ML location at liftoff and landing 
relative to location at disturbance onset.  
* p<.05 in follow up t-test 
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  Table 1. Characteristics of subject groups: mean +/- std. (range). 
Subject Group HC PD 
Age (years) 67 ± 11(48-79) 63 ± 9 (48-77) 
Height (cm) 165 ± 11 (150-188) 167 ± 7 (158-176) 
Mass (kg) 69 ± 11 (55-91) 76 ± 14 (55-94) 
UPDRS-Motor --- 20 ± 9 (9-38) 
UPDRS- Total --- 27 ± 15 (10-60) 
UPDRS #33 (Pull Test) --- 0.22 ± 0.44 (0-1) 
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Table 2. Initial stance and pull characteristics: mean (std). P-values 
determined from follow-up t-tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 HC PD p-value 
Mass (kg) 69 (11) 76(14) .195 
Height (cm) 165 (11) 167 (7) .658 
Stance Width (% height) 19 (3) 17 (6) .425 
COP Right Foot (% foot length) 27 (5) 27 (8) .970 
COP Left Foot (% foot length) 27 (3) 24 (16) .558 
Peak Force (N) 211 (22) 223 (29) .296 
Duration (ms) 275 (29) 267 (23) .480 
Impulse (N-ms) 22 (3) 23 (3) .756 
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                     Table 3. Average temporal characteristics: mean (std). 
 
 
 
 
 
 
 
* p<.05 in follow-up t-test
 HC PD p-value 
Reaction Time (ms) 124 (19) 123 (17) .910 
Weight Shift Time (ms) 222 (54) 500 (304) .023* 
Step Duration (ms) 113 (51) 153 (33) .076 
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Table 4. Average kinematic characteristics of the first step: mean (std). 
All angles are in degrees, step length and height are a percentage of 
subject height. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
* p<.05 in follow-up t-test
 HC PD p-value 
Liftoff Angle 1.51 (3.84) -4.10 (3.64) .016* 
Max PF S1 4.10 (1.66) 1.68 (1.67) .019* 
Max DF S1 0.866 (1.32) 4.89 (2.66) .004* 
Landing Angle -1.27 (3.91) -5.09 (5.24) .148 
Max PF S2 0.40 (0.642) 2.43 (4.10) .221 
Max DF S2 3.88 (3.15) 3.61 (3.44) .879 
Step Length 8.16 (3.66) 10.20 (4.56) .375 
Step Height 1.37 (1.95) 1.79 (2.51) .733 
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Table 5. Average kinetic characteristics of the first step: mean (std). All 
torques are normalized to body weight times height (N-m/kg-m); peak landing 
force is normalized by body weight (N/kg). P-values determined from follow-
up t-tests. 
 HC PD p-value 
Peak DF Torque S1 0.039 (0.050) 0.013 (0.026) .244 
Peak PF Torque S1 0.154 (0.051) 0.194 (0.072) .249 
Peak DF Torque S2 0.019 (0.022) 0.004 (0.006) .113 
Peak PF Torque   S2 0.031 (0.017) 0.033 (0.030) .860 
Peak Landing Force 12.80 (1.88) 11.36 (1.61) .149 
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Table 6. Average center of pressure location at liftoff and landing of the first 
step: mean (std). All values are relative to the COP position at disturbance 
onset. Positive values represent backwards movement. 
 HC PD p-value 
COP AP-liftoff (mm) 29.29 (25.32) 63.99 (48.91) .090 
COP ML-liftoff (mm) 128.4 (19.15) 125.0 (33.88) .669 
COP AP-landing (mm) 42.06 (16.84) 70.71 (36.63) .032* 
COP ML-landing (mm) 129.0 (21.87) 127.2 (33.36) .768 
 
* p<.05 in follow-up t-test 
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CHAPTER FOUR: SUMMARY 
 
Summary of Study 
The goal of this study was to investigate parameters of balance recovery that 
may be sensitive to postural instability early in the progression of Parkinson’s 
disease. Healthy control (HC) participants and participants with mild Parkinson’s 
disease (PD) responded naturally to a backwards pull at the waist. Video, motion, 
EMG, force plate, and load cell data were used to quantify the response in terms of 
strategy, temporal, kinematic, kinetic, and center of pressure parameters. Strategy 
parameters included whether the participant used a single or multiple step response, 
the number of steps in the response, and whether or not they were consistent in the 
choice of stepping limb over multiple trials. Temporal parameters included reaction 
time, weight shift time, and step duration. Kinematic parameters included step length, 
step height, ankle angle at liftoff and landing, and peak ankle plantarflexion/ 
dorsiflexion angle. Kinetic parameters included peak plantarflexion/dorsiflexion 
ankle torque, and peak vertical force. Center of pressure parameters included COP 
position at liftoff and landing of the first step. 
A few parameters showed differences between the two groups. The PD group 
was less consistent in their choice of stepping limb, but did not take more steps or use 
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a multiple step strategy more frequently than the controls. The PD group had a longer 
weight shift time, although the reaction times and step duration times were similar. 
The PD group showed different motion at the ankle prior to liftoff and were in 
dorsiflexion at liftoff whereas the HC were in plantarflexion. They did not show 
different ankle motion after liftoff. There were no group differences in peak torques 
or peak landing force; however the center of pressure was further posterior at landing 
in the PD, compared to the HC group. 
    
Conclusions and Recommendations 
This study found differences in the initial response to the backwards pull 
between healthy controls and the participants with Parkinson’s disease. The PD 
group, compared to the HC group, were less consistent in the choice of stepping limb, 
had a longer weight shift time, and showed a different motion at the ankle joint prior 
to liftoff. Most of the differences between the two groups were found in the 
movement preparation phase of the response (i.e. prior to liftoff of the first step). 
These results suggest that further investigation focused on the movement preparation 
stage may be able to identify early markers of postural instability. Further study is 
also necessary to determine the relationship between these parameters and clinically 
defined postural instability. It will also be necessary to develop clinical tests that can 
be used to monitor those parameters that are sensitive enough to detect the postural 
instability in the early stages of PD.  
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Study Limitations 
 This study has limitations. For one, there was a small sample size and large 
number of parameters tested. Since this study was designed to provide insights into 
where to look next, further studies with a more focused approach are necessary to 
validate these findings. Another limitation of the study is that the same number of 
trials was not used for every subject- only trials that involved multiple steps were 
included and average performance across the trials was analyzed. Further studies 
should be consistent in the number of trials. Finally, the subject population in this 
study had a wide age range, UPDRS score, and disease duration, but the effects of 
these conditions were not investigated.  Future studies should determine the effects of 
these conditions on each group.   
 
Further Study 
This study investigated a wide range of balance recovery parameters and 
found significant differences in a few of the parameters, almost all of which were in 
the initial movement preparation phase for the first step. The next step is to validate 
these findings in a more focused study with appropriate statistical power (estimated 
by preliminary power analysis to be 17 in each group based on an effect size of 0.8). 
Next, it is important to further dissect the initial stage of response. Future studies 
should look at the COP and anticipatory postural adjustments during the initial stage 
as well. Finally, these parameters should be investigated for sensitivity and specificity 
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to postural instability and fall risk by testing subjects in further stages of the disease 
and with a history of falls.
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APPENDIX A: EXPERIMENTAL PROTOCOL 
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Date of Screen: 
 
Subject name:   ________________________________________________                                                              
  Last    First   
 
“My name is _____.  I am calling from the Center on Aging at KU Medical Center.  I was 
given your name as someone who had indicated an interest in participating in a research 
study.  We are now beginning a study looking at how the brain controls our balance and how 
that might be related to risk of falling. If you think you might be interested in participating, 
and you have a few minutes, I’d like to describe the study to you.”   
 
Is subject interested?        YES NO 
 Comments:_____________________________________________________ 
 
If NO:  “Thank you for your time.  Would you be interested in being contacted for 
future studies or do you prefer that your name is removed from our list?” 
 Comments:________________________________________________________  
 
If YES: “Please feel free to ask questions at any time. This study is a two-part evaluation that 
will look at how Parkinson’s disease affects the ability of the brain to control our balance. We 
will be looking at those with Parkinson’s compared to healthy adults in the same age range.  
The first part of the study is a medical screen that we will do over the phone.  The phone call 
will take approximately 40 minutes and will include questions about current and previous 
health conditions. The final part of the study includes a visit to the Human Performance 
Laboratory in the Center on Aging where we will do a physical assessment and ask you to do 
four different tests including standing still while we record the natural sway of your body, 
starting to walk from rest, walking on a treadmill, and a balance recovery test. During all of 
the tests, you will be wearing a protective harness to ensure your safety. The final part of the 
test will take approximately 3 hours. There is no cost for participating in this study, nor are 
there any direct benefits to you.  Do you think you might be interested in participating? 
 
Interested?  
Notes:  
 
This study will be done at the Landon Center on Aging at KU Medical Center.  Would you 
have transportation to and from the KU Medical Center for this one visit?  
 
What is your age and date of birth? 
_________________________________________________ 
 
If you are interested in participating, I will have a research associate contact you to review 
your health history and schedule a time for you to visit the laboratory.  This phone call will 
take approximately 30-40 minutes. Is there a day/time that is convenient for you? 
__________________________________________________________________________ 
Thank you. 
 
***Please give this sheet to Molly McVey who will make the next phone call. Thanks. *** 
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Subject Identification Number: 
Date of Screen: 
 
Subject name:   ________________________________________________                                                              
  Last    First   
 
“My name is _____.  I am calling from the Center on Aging at KU Medical Center.  I was 
given your name as someone who had indicated an interest in participating in a research 
study.  We are now beginning a study looking at how the brain controls our balance and how 
that might be related to risk of falling. If you think you might be interested in participating, 
and you have a few minutes, I’d like to describe the study to you.”   
 
Is subject interested?        YES NO 
 Comments:_____________________________________________________ 
 ______________________________________________________________ 
 
If NO:  “Thank you for your time.  Would you be interested in being contacted for 
future studies or do you prefer that your name is removed from our list?” 
 Comments:________________________________________________________
 _________________________________________________________________ 
 
If YES: “Please feel free to ask questions at any time. This study is a one-time evaluation 
that will look at how Parkinson’s disease affects the ability of the brain to control our 
balance. We will be looking at those with Parkinson’s compared to healthy adults in the same 
age range.  There are two parts to this study. First, there is a medical screening procedure.  
The first part is done over the phone and will take approximately 20 minutes. This will 
include questions about current and previous health conditions. Once that is completed we 
will schedule you for a visit to the Human Performance Lab in the Center on Aging where we 
will do a physical assessment that and then do the balance testing. For the balance testing, we 
will ask you to do four different tests including standing still, starting to walk from rest, 
walking on a treadmill, and a balance recovery test.  For the balance recovery test, we will 
pull you backwards from the waist and you will have to regain your balance. During all of the 
tests, you will be wearing a protective harness to ensure your safety. The whole test will take 
approximately 3 hours. There is no cost for participating in this study, nor are there any direct 
benefits to you.  If you are still interested, I would like to ask you some questions to see if 
you would be able to participate in this study.” 
 
Notes:______________________________________________________________________
___________________________________________________________________ 
 
**If subject is excluded by any questions, stop the interview and explain to the subject the 
reason for exclusion.  Thank them for their time and willingness to participate. 
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Name: ___________________________________ Age:___________________ 
Birthdate:_________________________________________________________ 
Gender:  M F   
Address: __________________________________________________________  
Phone: ___________________________________________________________ 
Schooling/Occupation: _______________________________________________ 
Height: ________________Weight: ________________________ 
Are you currently participating in any other research studies? 
 
This study will require one trip to the Landon Center on Aging at KU Medical Center. Would 
you have transportation to and from the KU Medical Center for these two visits? 
 
 
Are you able to get out of bed and also use the bathroom without assistance from anything or 
anyone? 
 
Are you able to stand on your own for 10 minutes without assistance? 
(ex. Can you stand at the bathroom sink to do your morning care without having to hold to 
something?) 
 
 
SUMMARY OF MEDICAL SCREEN: 
 
 
 
Pass? If no, why not? 
 
 
 
Height: __________ Weight:__________Age:__________Gender: ____________ 
 
 
 
Comments:  
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Have you been diagnosed 
with: 
Yes No When Details Exclude? 
Ever had major surgery or 
amputation? 
    Yes if affects legs, 
not recovered 
completely 
Osteoporosis     Yes 
Brittle Bones     Yes 
Fibromyalgia? Constant 
aches and fatigue? 
    Yes if constant 
Arthritis     Yes if in legs 
Nerve Damage     Yes if in legs 
Heart Attack     Yes 
Heart Disease or problems 
(surgeries, valve 
replacement, angina, 
pacemaker?) 
    Yes 
Chest Pain from heart 
disease? 
    Yes 
Polio or Post Polio 
Syndrome 
    Yes 
Broken Bones? 
Compression fractures? 
    Yes if < 2 years 
ago and in leg or 
spine 
Ever had a hip, knee, or 
ankle replacement or 
surgery? 
    Yes  
Ever had a joint fusion?     Yes 
Diabetes? Thyroid 
conditions? 
    Yes if not 
controlled or if 
have neuropathy 
High Blood Pressure     Yes if not 
controlled on 
meds 
Neurological Disease (MS, 
ALS, Dementia, Seizure 
disorders, PD) 
    Yes 
Stroke or TIA     Yes 
Cancer, Leukemia, 
Lymphoma? 
    Yes if currently 
being treated 
Anemia     Yes if has had 
blood transfusion 
in last year 
Seizure     Yes 
Meniere’s Disease? Inner 
Ear Damage? Vertigo? Ear 
infection right now? 
    Yes 
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Acoustic Neuroma? 
Tinnitus? (ringing, 
buzzing in ears) Do you 
feel pressure in ears? 
    Yes if constant 
Do you have any 
problems with: 
Yes No How does it affect 
ADL? 
Exclude? 
Pain or stiffness in hips? 
Knee? Ankles? Back? 
Shoulder? 
   Yes if affects 
walking, standing 
Hip, Knee, or Ankle 
injury? 
   Yes if affects 
walking, standing 
Back Problems? If yes: 
• What motions cause 
pain (bending, 
twisting, lifting, quick 
movements?) 
• How irritable is the 
pain? 
• How do you treat the 
pain? 
• Have you seen a 
doctor? 
   Yes if brought on 
by walking, 
standing, quick 
movements, if 
brought on easily 
Muscle Problems in leg? 
Weakness in legs? Does it 
limit how far you can walk 
or how long you can 
stand? 
   Yes if affects 
walking, standing 
Poor circulation in legs 
causing them to become 
cold, numb, or causes 
cramping while walking, 
been diagnosed with 
PVD? Claudication? 
   Only if causes 
problems when 
walking or 
standing 
Lung disease? 
Emphezema? Chronic 
Bronchitis? SOB? DOE? 
   Yes if affects 
walking, standing 
Ever had a head or neck 
injury? 
   Not necessarily 
Gout or Psuedogout?    Not necessarily 
Foot problems?    Not necessarily 
Hearing Problems? 
Hearing aid? Last hearing 
exam? 
   Not necessarily 
Have you been 
hospitalized in the past 
year? Major illness in last 
year? 
   Not necessarily 
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Headaches    Not necessarily 
Neuropathy    Not necessarily 
Vision    Not necessarily 
Falls    Not necessarily 
Driving    Not necessarily 
Night Driving    Not necessarily 
Shortness of Breath    Not necessarily 
Edema (swelling of legs)    Not necessarily 
Fainting or 
lightheadedness? 
   Not necessarily 
Memory    Not necessarily 
Burning pain or weakness 
anywhere in body? 
   Not necessarily 
Depression    Not necessarily 
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MEDICATIONS: 
What medications are you currently taking? 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
OTC Medications: 
 
 
ACTIVITY: 
Are you able to leave house / apartment on your own? How often? 
___________________________________________________________ 
 
When you walk, do you walk with : Self walker/cane  person assist unable 
How far do you walk on a daily basis? ________ 
How often do you walk? _______ 
How long do you walk (duration) _______ 
 
Do you participate in any exercise/Activities? 
Type ________________________________________________ 
Sessions per week _____________________________________ 
Minutes / hours per session _______________________________ 
 
When you transfer from a sitting to standing position, do you do it:  
Alone With assistive device With person assist Unable 
 
When you transfer from lying down to sitting, do you do it: 
Alone With assistive device With person assist Unable 
 
Hand dominance L R  Leg dominance L R 
(Are you right or left-handed?)  (Which leg would you kick a ball with?) 
 
Recent vision screen? If yes, when? 
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BARTHEL INDEX: SEE FULL VERSION 
       With Help 
 Independent 
1. Feeding       5   10 
2. Moving from wheelchair to bed and return   5-10   15 
3. Personal toilet (wash face, comb hair, etc.)   0   5 
4. Getting on and off toilet (handling clothes, flush, wipe)  5  
 10 
5. Bathing self       0   5 
6. Walking on level surface     10   15 
7. Ascend and descend stairs     5   10 
8. Dressing (includes tying shoes, fastening)    5  
 10 
9. Controlling bowels      5   10 
10. Controlling bladder      5   10 
Is there anything else you can think of about your current or past health state that we might 
need to know?  
 
“With these initial questions it appears that you are eligible for the next step in the study.  The 
next step involves a physical evaluation by a physical therapist and geriatrician here at the 
Center on Aging.  The evaluation will take approximately one hour.  We are now scheduling 
participants for ______________.  Would you be able to come to the Center on Aging to 
participate during this time?” 
 
If NO: “We will be continuing to test more participants in the coming weeks and months.  
Can we contact you to schedule a time in future?”   
   
“We like to schedule to start in the morning or after lunch around 1:00…..*schedule a time 
with them. 
 
Is participant interested? 
 a. Visit scheduled _________________________________________ 
 b. Visit delayed (specify reason)______________________________ 
 c. Subject requests delay and reinquiry at a later date: _____________ 
 d. Subject and/or family expresses wish for no further contact. 
 
Notes: 
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Subject Identification Number: 
 
Date of Screen: 
 
Subject name:   ________________________________________________                                                              
  Last    First   
 
“My name is _____.  I am calling from the Center on Aging at KU Medical Center.  I was 
given your name by Dr. Lyons and Dr. Pahwa in the Parkinson’s Disease Center at KUMC as 
someone who had indicated an interest in participating in a research study.  We are now 
beginning a study looking at how Parkinson’s disease affects the ability of the brain to control 
our balance and how that might be related to risk of falling. If you think you might be 
interested in participating, and you have a few minutes, I’d like to describe the study to you.”   
 
Is subject interested?        YES NO 
 Comments:_____________________________________________________ 
 ______________________________________________________________ 
 
If NO:  “Thank you for your time.  Would you be interested in being contacted for 
future studies or do you prefer that your name is removed from our list?” 
 Comments:________________________________________________________
 _________________________________________________________________ 
 
If YES: “Please feel free to ask questions at any time. This study is a one time evaluation that 
will look at how Parkinson’s disease affects the ability of the brain to control our balance. We 
will have you do four different tests including standing still, starting to walk from rest, 
walking on a treadmill, and a balance recovery test.  For the balance recovery test, we will 
pull you backwards from the waist and you will have to regain your balance. During all of the 
tests, you will be wearing a protective harness to ensure your safety. Either before or after the 
balance testing, Dr. Lyons will do a clinical evaluation that will take approximately 15-30 
minutes. The whole session will take about 2.5-3 hours.  There is no cost for participating in 
this study, nor are there any direct benefits to you.  If you are still interested, I would like to 
ask you some questions to see if you would be able to participate in this study.” Next, I will 
be asking about your previous and current health and this phone call will take approximately 
30 minutes.  Are you still interested? 
 
Notes:______________________________________________________________________
___________________________________________________________________ 
 
**If subject is excluded by any questions, stop the interview and explain to the subject the 
reason for exclusion.  Thank them for their time and willingness to participate. 
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Name: ___________________________________ Age:___________________ 
Birthdate:_________________________________________________________ 
Gender:  M F   
Address: __________________________________________________________  
Phone: ___________________________________________________________ 
Schooling/Occupation: _______________________________________________ 
Height: ________________Weight: ________________________ 
Are you currently participating in any other research studies? 
 
This study will be done at the Landon Center on Aging at KU Medical Center. Would you 
have transportation to and from the KU Medical Center for this one visit? 
 
 
Are you able to get out of bed and also use the bathroom without assistance from anything or 
anyone? 
 
Are you able to stand on your own for 10 minutes without assistance? 
(ex. Can you stand at the bathroom sink to do your morning care without having to hold to 
something?) 
 
 
SUMMARY OF MEDICAL SCREEN: 
 
 
 
Pass? If no, why not? 
 
 
 
Height: __________ Weight:__________Age:__________Gender: 
____________ 
 
 
 
Comments:  
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Have you been 
diagnosed with: 
Yes No When Details Exclude? 
Ever had major 
surgery or 
amputation? 
    Yes if affects legs, 
not recovered 
completely 
Osteoporosis     Yes 
Brittle Bones     Yes 
Fibromyalgia? 
Constant aches and 
fatigue? 
    Yes if constant 
Arthritis     Yes if in legs 
Nerve Damage     Yes if in legs 
Heart Attack     Yes 
Heart Disease or 
problems (surgeries, 
valve replacement, 
angina, pacemaker?) 
    Yes 
Chest Pain from heart 
disease? 
    Yes 
Polio or Post Polio 
Syndrome 
    Yes 
Broken Bones? 
Compression 
fractures? 
    Yes if < 2 years ago 
and in leg or spine 
Ever had a hip, knee, 
or ankle replacement 
or surgery? 
    Yes  
Ever had a joint 
fusion? 
    Yes 
Diabetes? Thyroid 
conditions? 
    Yes if not controlled 
or if have neuropathy 
High Blood Pressure     Yes if not controlled 
on meds 
Neurological Disease 
(MS, ALS, Dementia, 
Seizure disorders, 
PD) 
    Yes 
Stroke or TIA     Yes 
Cancer, Leukemia, 
Lymphoma? 
    Yes if currently being 
treated 
Anemia     Yes if has had blood 
transfusion in last 
year 
Seizure     Yes 
Meniere’s Disease? 
Inner Ear Damage? 
    Yes 
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Vertigo? Ear 
infection right now? 
Acoustic Neuroma? 
Tinnitus? (ringing, 
buzzing in ears) Do 
you feel pressure in 
ears? 
    Yes if constant 
Do you have any 
problems with: 
Yes No How does it affect 
ADL? 
Exclude? 
Pain or stiffness in 
hips? Knee? Ankles? 
Back? Shoulder? 
   Yes if affects 
walking, standing 
Hip, Knee, or Ankle 
injury? 
   Yes if affects 
walking, standing 
Back Problems? If 
yes: 
• What motions 
cause pain 
(bending, 
twisting, lifting, 
quick 
movements?) 
• How irritable is 
the pain? 
• How do you treat 
the pain? 
• Have you seen a 
doctor? 
   Yes if brought on by 
walking, standing, 
quick movements, if 
brought on quickly 
Muscle Problems in 
leg? Weakness in 
legs? Does it limit 
how far you can walk 
or how long you can 
stand? 
   Yes if affects 
walking, standing 
Poor circulation in 
legs causing them to 
become cold, numb, 
or causes cramping 
while walking, been 
diagnosed with PVD? 
Claudication? 
   Only if causes 
problems when 
walking or standing 
Lung disease? 
Emphezema? 
Chronic Bronchitis? 
SOB? DOE? 
   Yes if affects 
walking, standing 
Ever had a head or 
neck injury? 
   Not necessarily 
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Gout or Psuedogout?    Not necessarily 
Foot problems?    Not necessarily 
Hearing Problems? 
Hearing aid? Last 
hearing exam? 
   Not necessarily 
Have you been 
hospitalized in the 
past year? Major 
illness in last year? 
   Not necessarily 
Headaches    Not necessarily 
Neuropathy    Not necessarily 
Vision    Not necessarily 
Falls    Not necessarily 
Driving    Not necessarily 
Night Driving    Not necessarily 
Shortness of Breath    Not necessarily 
Edema (swelling of 
legs) 
   Not necessarily 
Fainting or 
lightheadedness? 
   Not necessarily 
Memory    Not necessarily 
Burning pain or 
weakness anywhere 
in body? 
   Not necessarily 
Depression    Not necessarily 
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MEDICATIONS: 
What medications are you currently taking? 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
Name: _________________________ Amt _______________Time________________ 
**Testing should occur 1-2 hours after last dose of medication.  
 
OTC Medications: 
 
 
ACTIVITY: 
Are you able to leave house / apartment on your own? How often? 
___________________________________________________________ 
 
When you walk, do you walk with : Self walker/cane  person assist unable 
How far do you walk on a daily basis? ________ 
How often do you walk? _______ 
How long do you walk (duration) _______ 
 
Do you participate in any exercise/Activities? 
Type ________________________________________________ 
Sessions per week _____________________________________ 
Minutes / hours per session _______________________________ 
 
When you transfer from a sitting to standing position, do you do it:  
Alone With assistive device With person assist Unable 
 
When you transfer from lying down to sitting, do you do it: 
Alone With assistive device With person assist Unable 
 
Hand dominance L R  Leg dominance L R 
(Right or left-handed?)   (Which leg would you kick a ball with?) 
 
Recent vision screen? If yes, when? 
 
Is there anything else you can think of about your current or past health state that we might 
need to know?  
 
 
 
 
 
When were you first diagnosed with Parkinson’s disease?  
 
 84
What was the first symptom you experienced?  When did you experience the first symptom? 
  
 
Are you affected on one or both sides of your body? Which side is more affected? 
 
 
Do you feel like you have bad balance? Do you have difficulty maintaining your balance 
while: standing still, walking, changing positions?   
 
 
 
Have you fallen in the past year?  
Event: _______________________Date:________________Injury:_________________ 
Circumstances: ___________________________________________________________ 
Event: _______________________Date:________________Injury:_________________ 
Circumstances: ___________________________________________________________ 
Event: _______________________Date:________________Injury:_________________ 
Circumstances: ___________________________________________________________ 
 
 
How often do you fall? 
 
 
Do you currently use any devices to assist you (canes, walker, etc?) 
 
 
 “With these initial questions it appears that you are eligible for this study.  We are now 
scheduling participants for ______________.  Would you be able to come to the Center on 
Aging to participant during this time?” 
 
If NO: “We will be continuing to test more participants in the coming weeks and months.  
Can we contact you to schedule a time in future?”   
   
“We like to schedule to start in the morning or after lunch around 1:00…..*schedule a time 
with them. 
 
Is participant interested? 
 a. Visit scheduled _________________________________________ 
 b. Visit delayed (specify reason)______________________________ 
 c. Subject requests delay and reinquiry at a later date: _____________ 
 d. Subject and/or family expresses wish for no further contact. 
 
Notes: 
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Dear ___________________, 
 
Thank you for agreeing to participate in our research study!   
 
Your appointment is scheduled for ___________________. and will be about 3 hours long.  
 
This study looking at how Parkinson’s disease affects balance will be conducted in the 
Human Performance Lab, which is located on the first floor of the Landon Center on Aging at 
KU Medical Center.  Parking is located in front of the building.  A map is included with this 
letter to help you locate us. 
 
When you arrive at the Center on Aging, please have a seat in the main waiting area on the 
first floor.  A research associate will be out shortly to greet you and bring you to the testing 
area. 
 
Please note that this study is not being conducted through the Parkinson’s Disease Center or 
the Neurology Clinic.  Therefore, they will not have a record of your appointment. If you 
have any questions or need to reschedule your appointment, please contact Molly McVey at 
785-218-2714.  
 
 
Thank you, 
 
 
 
Molly McVey 
Graduate Research Assistant  
Human Performance Lab 
Center on Aging, KUMC 
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PHYSICAL EXAMINATION DATA 
 
Height  Weight  
Sitting BP-P   
Supine BP-P Standing BP-P 
Strength Left Right  Left Right 
Shld Abd   Hip Ext   
Biceps   Hip Abd   
Triceps   Hip Add   
Wst Flex   Knee Ext   
Wst Ext   Knee Flex   
Grip   Ankle Df   
Hip Flex   Ankle Pf   
Reflexes   Patellar   
Biceps   Achilles   
Triceps   Babinski   
Sensory Position Vibration Pin Prick 
 Left Right Left Right Left Right 
Upp Ext       
Low Ext       
Cerebellar Left Right 
Fing-Nose   
Heel-Shin   
Cardiac 
Pulm 
Ears 
Gross Cranial Nerves Left Right (Other) Left Right 
 EOM      
 Facial      
   
Tone Left Right 
Cogwheeling   
Station and Gait 
Romberg 
Gait 
Musculoskeletal deformities and contractures 
Joint/Extremity (pain ROM) 
Lymphatic 
Back 
Neuro Tremor 
 Rigidity 
 Dyskinesia 
 Spasticity 
Other/comments 
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BARTHEL INDEX 
 
INSTRUCTIONS: The Barthel Index is a record of what a patient does not a record of what a 
patient could do.  Full credit is not given for an activity if the patient needs even minimal 
help/supervision.  A score of (0) is given when a patient cannot meet the criteria as defined. 
Circle the appropriate answer to each question. 
 
1.  Today, are you able to feed yourself? 
 
10:  Independent; feeds self from tray or table; can put on assistive device if 
needed; accomplishes feeding in reasonable time. 
5:  Assistance necessary with cutting food, etc. 
0:  Cannot meet criteria 
88:  Contraindicated due to _________________________________________ 
 
 
2.  Today, are you able to get out of bed or into a chair? 
  
 15:  Independent in all phases of this activity 
10:  Minimal help needed or patient needs to be reminded or supervised for safety 
of one or more parts of this activity. 
5: Patient can come to sitting position without help of second person, but needs 
to be lifted out of bed and assisted with transfers 
0:  Cannot meet criteria 
88:  Contraindicated due to _______________________________________ 
 
3.  Today, are you able to wash your face, brush your teeth, brush your hair, etc.? 
 
5: Can wash hands, face; combs hair, cleans teeth. Can shave (males) or apply 
makeup (females) without assistance; females need not braid or style hair. 
0:  Cannot meet criteria 
 88:  Contraindicated due to________________________________________ 
 
4.  Today are you able to get on and off the toilet? 
 
10:  Able to get on and off the toilet, fastens/unfastens clothes; can use toilet 
paper without assistance.  May use wall bar or other support if needed; if 
bedpan is necessary, patient can place it on chair, empty, and clean it. 
5: Needs help because of imbalance or other problems with clothes or toilet 
paper 
0:  Cannot meet criteria 
88:  Contraindicated due to _________________________________________ 
 
 
 
5.  Today, are you able to bathe yourself? 
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5: May use tub, shower, or sponge bath.  Patient must be able to perform all 
functions without another person being present. 
0:  Cannot meet criteria 
88:  Contraindicated due to _________________________________________ 
 
6.  Today, are you able to walk without help? 
 
15:  Patient can walk at least 50 yards without assistance or supervision; may use 
braces, prostheses, crutches, canes, or walker, but not a rolling walker. Must 
be able to lock/unlock braces, assume standing or seated position, get 
mechanical aids into position for use and dispose of the mechanical aids 
when seated (putting on and off braces should be scored under dressing). 
10:  Assistance needed to perform above activities, but can walk 50 yards with 
little help. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
 
7.  Today, are you able to use a wheelchair? (Do not score if patient competes score  for 
walking- item #6). 
 
5:  Patient cannot ambulate, but can propel wheelchair independently; can go 
around corners, turn around and maneuver chair to table, bed, toilet, etc; 
must be able to push chair 50 yards. 
0:  Cannot meet criteria 
88:  Contraindicated due to________________________________________ 
 
8.  Today, are you able to walk up and down stairs? 
 
10: Able to go up and down flights of stairs safely without supervision; using 
canes, handrails, or crutches when needed and can carry these items as 
ascending/descending. 
5: Needs help or supervision of any of the above items. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
 
9.  Today, are you able to dress and undress yourself? 
 
10:  Able to put on, fasten, and remove all clothing; ties shoelaces unless 
necessary adaptations used.  Activity includes fastening braces and corsets 
when prescribed; suspenders, loafer shoes, and dresses opening in the front 
may be used when necessary.   
5: Needs help putting on, fastening, or removing clothing; must accomplish at 
least half of task alone within reasonable time; women need not be scored on 
use of brassiere or girdle undless prescribed. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
 
10.  Today, are you able to control your bowels? 
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10:  Able to control bowels and have no accidents.  Can use a suppository or take 
an enema when necessary (as for spinal cord injury patients who have had 
bowel training). 
5: Needs help in using a suppository or taking an enema or has occasional 
accidents. 
0:  Cannot meet criteria 
88:  Contraindicated due to _______________________________________ 
 
11.  Today, are you able to control your bladder? 
 
10:  Able to control bladder day and night. Spinal injury patients must be able to 
put on external devices and leg bags independently, clean and empty bag, 
and must stay dry day and night. 
5:  Occasional accidents occur, cannot wait for bedpan, does not get to toilet in 
time or needs help with external device. 
0:  Cannot meet criteria 
88:  Contraindicated due to ________________________________________ 
 
12. Information for today’s Barthel data gathered from: 
 01: Patient 
 02: Proxy- Caregiver 
 03: Proxy- Other 
 04: Chart 
 05: Both patient and proxy 
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Environmental Assessment: 
 
1. Do you live in a home, apartment, or assisted living facility? 
 
 
 
2. Do you have stairs in your home? How often do you use them? 
 
Staircase #1: _______________________ Frequency: _______________________ 
Staircase #2: _______________________ Frequency: _______________________ 
Staircase #3: _______________________ Frequency: _______________________ 
Staircase #4: _______________________ Frequency: _______________________ 
 
 
3. Do you live alone? With a spouse or partner? Do you have a caretaker (live-in or 
otherwise)? 
 
 
 
4. Do you use any type of assistive devices at any time during a normal day? (Walkers, 
canes, etc?) 
 
 
 
5. Do you ever use assistance from someone else during a normal day? (Taking a hand 
to go down steps, get out of a car, etc.)? 
 
 
6. Have you ever modified anything in your home to reduce the risk of falling? When? 
 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
Modification: __________________________ Date: ________________________ 
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PD Pilot Protocol 
Subject Setup 
Participants will be set up at the start of the session.  This setup will remain the same for all 
protocols. 
 
Consent  
Clarify history (falls in previous 3 months, severity and duration, medication status) 
Mini-mental exam 
Change into standard shorts, shoes, and socks. 
 
Measurements and EMG Placement 
Have subject lie down in setup room; take the following measurements while subject is lying 
down: 
Leg Length (distance from ASIS to medial ankle via knee) 
Inter-ASIS Distance  
Place EMGs: bilateral TA, solius, hamstring, quad 
 Tips for placement: 
 Solius: 
Hamstring: have subject lay on side, then hold their lower leg and ask them to try to 
bend their leg while you resist.  
Have subject stand for the following measurements: 
Knee Width (between femoral condyles) 
Ankle Width (align measuring device with axis of ankle) 
Ankle Height 
Foot Width 
Foot Length 
Calf Circumference 
Thigh Circumference 
Height 
Weight 
 
EMG:  
Bilateral application of electrodes to the following muscles: 
Gastroc, solius, quadriceps, anterior tib, hamstring.  
 
Connect EMG as follows: 
EMG lead Muscle  EMG out-> Vicon BNC in 
#1   R TA     9 – 1 
#2   R gatroc  10 – 2  
#3   R solius/ham  11 – 3  
#4  R quad   12 – 4    
#5  L TA   13 – 5  
#6   L gatroc  14 – 6  
#7   L solius/ham  15 – 7  
#8  L quad   16 – 8 
Black   ground   17 – 9 
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Vicon markers 
15 14 mm markers will be placed on the lower body as follows (see Vicon PlugIn Gait 
marker placement guide for more information about specific placement methods): 
Complete Setup: Bilateral – ASIS, sacrum, thigh, knee, shin, ankle, heel, toe 
Knee alignment devices (KADS) will be used during the patient setup to establish the knee 
joint coordinate system. 
Modified Setup: Bilateral- greater trochanter, thigh, knee, shin, ankle, heel, toe 
 
Marker Placement Tips: 
 ASIS/Sacrum: tape around the waist, and then attach markers to the tape 
Thigh: Find greater trochanter, have subject rotate their foot to make sure you have it, 
then place marker on the line between the greater troch and knee. Place the marker on 
the right side higher than the left side. 
Knee: Identify tibial plateau, then move back and up to find the femoral condyle- 
Place KADS first, then replace with individual markers. 
Shin: Place on line between axis of knee and axis of ankle, marker on the right side 
higher than left 
 Heel: Place on shoe, at same height of toe marker 
 Ankle: Place marker in line of joint 
 Toe: 2nd metatarsal head  
 
• Put harness on 
• Put EMG belt on 
 
Data Collection 
Walk the subject over to the forceplates for the EMG check and subject calibration trials. 
 
• Subject Calibration Trial 
• Remove KADs and replace with knee markers 
• EMG check trial 
 
Sway (trial type: PD_sway/ trial name: sway1) 
Sway testing consists of three trials in each of two different conditions, eyes open (EO) and 
eyes closed (EC). Force plate, EMG, and motion data will be collected. Each test will last 30 
seconds with 30 seconds of rest in between trials. 
Should have complete marker setup, EMG on gastroc, SOLEUS, TA, quads 
 
• Have participant stand comfortably with one foot on each force plate. Feet should be 
shoulder wide and at a self-selected angle.  Arms rest to the side and the subject is 
looking at a marker placed 5 feet in front of the at approximately eye height.  
• Attach safety harness 
• Check EMG and visibility of markers  
• Read script to the participant 
• Before each test, remind the participant of the condition being tested (EO or EC). 
• Disconnect Solius EMG channel and connect to hamstring electrode 
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Balance Recovery (trial type: general w/analog/ trial name: pull1) 
The balance recovery testing consists of 3 backwards pull trials.  Force plate, EMG, and 
motion data will be collected during all trials.  The weight-drop device will be used to pull 
the participant. 
Should have modified marker setup (no sacrum or ASIS, but including great troch 
markers), EMG on gastroc, hamstring, TA, quad 
 
• Attach safety harness 
• TAKE STATIC TRIAL IN MODIFIED MARKER SETUP 
• Put on the rigid belt  
• Measure waist height, adjust pull device to 8.7% of waist height 
• Attach pull device cable 
• Read script, explaining task (no practice trials) 
• Research assistant should spot the participant throughout all trials 
• Once subject is ready, release the weight-dropping mechanism 
• Tell the subject to relax after they have regained their balance for three seconds 
• Check trial in Vicon for marker visibility  
• Perform a total of 3 trials with 30 seconds rest in between trials 
• Disconnect safety harness, cable to pull device, and remove belt 
 
Gait Initiation (trial type: general w/analog/ trial name: gait_ini1) 
Participants will perform 5 gait initiation trials, all starting from standing on a forceplate. 
EMG, force and movement data will be collected. 
Should have complete marker setup, foot switches, EMG on gastroc, hamstring, TA, quad 
 
• Attach foot switches and foot switch belt 
• Attach foot switches to scope to check and monitor foot switch signal 
• Have participant stand in collection area. 
• Attach safety harness 
• Read the script to the participant. 
• Do a few practice trials to get a good starting location ensuring clean FP strikes. 
• Participant should start each trial with their feet in a comfortable stance and their 
arms relaxed at their sides. 
• At the end of the trial, remove the light switch cable and replace with a grounding 
resistor to AUX 4. 
• A research assistant should be spotting the participant throughout. 
 
Gait (trial type: PD_gait/ trial name: gait) 
Participant will walk on the treadmill for 3 minutes at a self-selected speed.  EMG and 
movement data will be collected. 
Should have complete marker setup, foot switches, EMG on gastroc, hamstring, TA, quad 
 
• Move treadmill into the Vicon collection volume under the safety support. 
• Have participant put on safety harness. 
• Attach foot switches and foot switch belt 
• Attach foot switches to scope to check and monitor foot switch signal 
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• Instruct participant to step onto the treadmill. 
• Attach the cable to the safety harness. 
• Attach kill switch to subject’s clothing. 
• Power up the treadmill. 
• Read the script to the participant, explaining the tasks. 
• Slowly increase the speed of the treadmill until the desired speed is reached. Record 
the final speed on the data collection sheet. 
• Once the participant has reached a comfortable gait begin data collection. 
• At the end of data collection, inform participant they are finished and then stop the 
treadmill (manually decrease the speed to zero). 
• Remove safety cable and assist the participant in stepping off the treadmill. 
 
Take another subject calibration trial (should have two subject calibration trials- one 
for use with br, one for all others) 
 
Take another force plate zero trial 
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PD Pilot Protocol: Checklist 
 
 
Start Equipment Setup: 
_____Check Vicon camera positions 
_____Cables from force plate amplifiers are labeled “Vicon BOB” 
_____BNC connectors from EMG are connected to Vicon BOB. 
_____Connect video camera 
_____Connect pull device – normal (AUX1), shear (AUX2) 
_____Balance force plates 
 
Start Subject Setup: 
_____Consent  
_____Clarify history (falls in previous 3 months, severity and duration, medication status) 
_____Mini-mental exam 
_____5 Self-Report Tests  
 
Complete Equipment Setup: 
_____Complete Vicon session start-up as in Vicon Collection Procedures (do not calibrate 
more than 30 minutes prior to testing) 
_____Check system configuration (MJF Pilot), analog setup and control setup 
_____Zero analog channels for the force plates while in correct session 
_____Collect a FP zero trial for tracking drift (trial name: FPzero)  
_____Calculate appropriate weight for pull and load pull device (see paper) 
_____Test Pull Device 
_____Place “GO” switch box and target  
 
Complete Subject Setup: 
_____Measurements and EMG Placement 
_____Vicon markers 
_____Put harness on 
_____Put EMG belt on 
_____Place KADs for subject calibration trial 
 
Data Collection: 
_____Check to make sure Vicon is setup for this experiment 
_____Collect a subject calibration trial (trial type: subject calibration/ trial name: static) 
_____Check that movie camera is working  
_____Check to make sure all markers are visible  
_____Remove KADs and replace with knee markers 
_____Collect EMG trial (trial type: analog only/ trial name: EMGcheck) 
_____Check EMG signal (viewÆnew analog data) (shift-t to zoom) 
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Sway (trial type: PD_sway/ trial name: sway1) *Comment EO/EC in Vicon* 
3 EO/3 EC Each test will last 30 seconds with 30 seconds of rest in between trials. 
Should have complete marker setup, EMG on gastroc, SOLEUS, TA, quads 
 
_____Disconnect Solius EMG channel and connect to hamstring electrode 
 
Balance Recovery (trial type: general w/analog/ trial name: pull1) 
3 Backward Pull Trials 
Should have modified marker setup (no sacrum or ASIS, but including great troch 
markers), EMG on gastroc, hamstring, TA, quad 
 
_____Change markers: move calf and thigh markers out of alignment with knee, ankle, and 
hip markers. Add a great troch marker if not already in place. Remove ASIS markers. 
_____Take a static trial for use with BR (w/troch markers) 
_____ Put on the rigid belt 
_____Calculate weight drop height (8.7% of waist height) and adjust- measured from brushes 
_____Perform a total of 3 trials with 30 seconds rest in between trials 
_____Check each trial in Vicon 
_____Remove belt 
 
Gait Initiation (trial type: general w/analog/ trial name: gait_ini1) 
5 trials, all starting from standing on a force plate.  
Should have complete marker setup, foot switches, EMG on gastroc, hamstring, TA, quad 
 
_____Connect foot switch to Vicon BOB- AUX3 
_____Connect light switch to Vicon BOB- AUX4 
_____Adjust safety harness so that it is moveable 
_____Attach foot switches and foot switch belt 
_____Attach foot switches to scope to check and monitor foot switch signal 
_____Check each trial in Vicon 
_____At the end of all trials, remove the light switch cable and replace with a grounding 
resistor to AUX 4. 
 
Gait (trial type: PD_gait/ trial name: gait) 
Participant will walk on the treadmill for 3 minutes at a self-selected speed.   
Should have complete marker setup, foot switches, EMG on gastroc, hamstring, TA, quad 
 
_____Attach foot switches and foot switch box, check signal on scope. 
_____Take another force plate zero trial 
_____Make sure that you have two static trials 
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Parkinson’s Pilot Study Scripts 
 
Postural Sway 
 
“For this set of tests you will stand here with your hands to your sides and have either your 
eyes focused on the target in front of you or have them closed.  We will do several trials 
with rest in between. I will tell you when to begin each trial and I will tell you when to 
relax.” 
 
EO: 
Instructions to subject:   
“For this test, you will stand as still as possible.  Focus your gaze at the target in front of 
you”   
 
EC: 
Instructions to subject:   
“For this test, you will stand as still as possible with your eyes closed.  Keep your eyes 
closed until the end of the trial.” 
 
Gait Initiation 
 
5 trials start with feet on forceplates (capture push off and first step. 
 
Instructions to subject:  
“For this set of tests you will start standing still and then begin walking when you see the 
green light. Keep walking until I tell you to stop. You will take approximately 3-4 steps. We 
will do several trials with rest in between and there will be two different starting positions.”  
 
Repeat for each trial: 
“For this test, you will stand here as still as possible and when you see the green light you 
will start walking forward, looking ahead while you walk.” 
 
Balance Recovery 
 
Instructions to subject: 
“This study will let us look at your response to a balance disturbance.  You will be asked 
to stand here on these force plates and a cable will be attached to your waist. The cable 
will pull you backwards and you need to regain your balance. We will have you repeat 
this several times.  We will explain each step and give you a rest between trials.” 
“First we will have you put on this waist belt, which will be attached to the cable that 
will pull you for each trial.  For your safety, you will wear a safety harness.  The harness 
will catch you if you are unable to regain your balance.” 
“Now, we will have you place your right foot on this plate and your left one on this plate.  
Stand comfortably with your feet approximately shoulder-width apart. Please stand quietly 
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with your hands at your sides. Please remain as still as possible before and after you regain 
your balance, until I tell you to relax. Do you have any questions? 
“Okay, now we will start the test.  Please remember to stand up straight and remain still 
before the pull and after you step.” 
 
Gait 
 
Instructions to subject: 
“For this test you will walk on this treadmill for approximately 3 minutes at a pace that is 
comfortable for you. First we will determine a pace and then the test will begin. Again, you 
will wear a safety harness that will catch you in the event that you lose your balance.  Also, 
if at any time you feel uncomfortable, you can push this button and the treadmill will stop 
abruptly.” 
“First, we will start the treadmill slowly and choose a speed that feels like a comfortable, 
normal walking pace to you.  Do you have any questions?” 
(Choose pace) 
“Now, we will start the test. Just continue to walk normally. The test will last approximately 
3 minutes.” 
 
 110
Parkinson’s Test 
 
Date: ____________  Time: ____________  Subject #: ___________ 
Engineer: ______________  
Engineer: ______________ 
PT: ___________________ 
 
PD Duration: ____________ 
 
Medications: 
Name: ____________ Frequency: ___________  Last Dose: ___________ 
Name: ____________ Frequency: ___________  Last Dose: ___________ 
Name: ____________ Frequency: ___________  Last Dose: ___________ 
 
Fall History: 
Falls in previous 3 months: 
Date: _____________ Description: __________________________________ 
Date: _____________ Description: __________________________________ 
Date: _____________ Description: __________________________________ 
Date: _____________ Description: __________________________________ 
 
Mini-Mental Score: ___________ 
 
Measurements: 
Leg Length (ASIS to medial ankle via knee):    L: ________  R: _________ 
Inter ASIS distance:     ________________________ 
Knee Width (between femoral condyles):   L: ________  R: _________ 
Ankle Width:      L: ________  R: _________ 
Ankle Height:     L: ________ R: _________ 
Foot Width:      L: ________ R: _________ 
Foot Length:      L: ________ R: _________ 
Calf Circumference:     L: ________ R: _________ 
Calf Length:      L: ________ R: _________ 
Thigh Circumference:    L: ________ R: _________ 
Thigh Length:      L: ________ R: _________ 
Height:       ________________________ 
Weight:       ________________________ 
Waist Height:      ________________________ 
    
Testing Notes: 
 
Subject Calibration Trial 
Static 1: ________________________________________________________________ 
Static 2: ________________________________________________________________ 
EMG Check: ____________________________________________________________ 
 
Sway(PD_sway) 
Sway1: _________________________________________________________________ 
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Sway2: _________________________________________________________________ 
Sway3: _________________________________________________________________ 
Sway4: _________________________________________________________________ 
Sway5: _________________________________________________________________ 
Sway6: _________________________________________________________________ 
 
Balance Recovery (general w/analog capture) 
Pull1: __________________________________________________________________ 
Pull2: __________________________________________________________________ 
Pull3: __________________________________________________________________ 
 
 
Gait Initiation (general w/analog capture) 
Gait_ini1: ______________________________________________________________ 
Gait_ini2: ______________________________________________________________ 
Gait_ini3: ______________________________________________________________ 
Gait_ini4: ______________________________________________________________ 
Gait_ini5: ______________________________________________________________ 
 
 
Gait (PD_gait) 
Gait: ___________________________________________________________________ 
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Vicon Collection Procedure  
MJF pilot study 
 
Camera and Volume setup  
• Set camera locations based on Vicon Camera Setup Sheet for study. 
• Check that the volume and surrounding area is free of reflective objects. 
 
Check connections with peripheral equipment 
• Force plates: Attach the cables labeled “Vicon Raw” to the force plate amplifiers.  
These terminate at the Vicon BOB.  Make sure the cable from the Vicon BOB is 
connected to the data station.  Power on force plates at least 15 minutes before 
collection. 
• EMG:  Attach BNC to the Vicon BOB using channels 1-8. 
• Pull device input: Connect to the Vicon BOB - normal to AUX1, shear  to AUX2.   
• Video (If using): Attach fire wire from camera to the fire wire port of PC.   If the 
camera cord length is too short, you may use the Dazzle, connecting the fire wire 
from the camera to Dazzle and fire wire from Dazzle to the PC.  Make sure the 
Dazzle and camera are powered on. The Dazzle should be set at “Pass through”. 
 
Power up 
• Power up and log into computer 1st, then power up Vicon Datastation.  If you do not 
do this in the correct order, the computer will not be able to find the network. 
   
Turn on all equipment, including cameras and strobes at least 15 minutes before 
start of a session. 
 
 
 
 
Session setup: 
• Start Workstation  
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• Open Eclipse. In the correct database (BrowseÆ D: Capture\Data\ Antonis.enf), 
double click on the project level (green icon) to activate it. With this level 
highlighted, select System| System Configuration 
o Select “MJF_pilot” system configuration (not a bad idea to check analog 
setup to confirm the change in the system settings).  The session settings are 
taken from the active config, so if you build the session before making this 
change, your settings will be incorrect and you will need to start over. 
• Click System | Control Setup and ensure that no remote triggers are enabled (no 
checks). 
• Click System | Start Link to establish a connection to the datastation.  This should 
illuminate the camera strobes. Allow the cameras to be on for 10 minutes before 
calibrating.  
• Click System | Live Monitors to look at the capture volume. Check and adjust camera 
placement to ensure your capture space is covered and viewed by cameras (a quick 
check of the volume by walking through it with the wand). 
o If you are not receiving data from a camera, unplug the line to the datastation 
for that camera (1-3 or 4-6) and replug it in.  This will reinitialize that group 
of cameras.  
• Check camera angles and camera sensitivity in Workstation 
• Go to System | Calibrate cameras. Make sure all cameras are selected and that the 
proper calibration props are selected (clinical L-frame and 500mm wand). 
• Set the calibration L-frame in place to create the desired coordinate system. 
• Perform a static calibration followed by dynamic calibration* and check for 
acceptable calibration values.  
o Make sure the wand stays in the calibration volume during the capture.   
• Enter the calibration information in the log. 
Wand visibility – measure of whether both markers are 
visible to each camera.  Higher is better (<50% = failed). 
Static reproducibility – how well the L frame measured 
matches expected measurements.  Lower is better. 
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Residuals - < 0.1% of the distance from the cameras to the 
center of the capture volume.  Check the log for acceptable 
values, typically 1-1.6 for larger volumes. 
 
• Build the session (add a new patient, and a new session). 
• With the session highlighted, go to System | Calibrate Analog Zero Levels and select 
the force plate channels.  Make sure that the force plates are completely setup before 
this step (powered on, balanced, etc.) and that there is no load on them. 
• Go to System | Live Movie to check the view of the video camera if using it.   
Begin Capture with Subject  
• Once subject is set up with markers, have them stand in the capture volume. Make 
sure there is nothing besides markers which appear on the subject (reflective jewelry 
etc). 
• To capture a trial: 
o Select the appropriate trial type  
o Check that the appropriate data will be collected by clicking Types. 
o Give the trial a name and any description desired.  
*Note 1: make sure that the person performing the calibration is not wearing anything 
reflective.  This can be checked in live monitor by having the person walk around the 
capture volume.   Also, ensure that your subject is not in view of the cameras if 
he/she has markers on. 
 Note 2: if a camera is moved at all during testing you must recalibrate! 
 
**Checking and preliminary processing 
• You may want to use diagnostic mode to check video quality.  
• Analog data can be checked using Graph | Analog.  This data will be the analog data 
as acted on by the scale factors specified for each channel in the analog setup.  The 
raw data can be visualized by Window | New Analog Data or by double clicking the 
‘A’. 
Control the data presentation by the following keys with or without shift key: 
L - # of traces 
T – timeline 
G – gain  
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APPENDIX B: INVERSE DYNAMICS MODEL1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Modified from Vaughan, C.L., B.L. Davis, and J.C. O’Connor, Dynamics of Human 
Gait. 1992, Champaign, IL: Human Kinetics Publishers. 
 
 Indicates modification to model calculations 
Indicates change to model figures 
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